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1. INTRODUCTION 
 
1.1 Cellular protein quality control systems 
 
1.1.1 Proteins - the worker molecules of the cell 
In the cell, a multitude of processes are active in parallel at any time, among them 
transcription and translation, catabolic and anabolic metabolism, and respiration to 
mention only a few. In all types of cells, proteins are the key factors that execute and 
maintain these processes. Each protein is synthesized as a linear chain of a defined amino 
acid sequence. In order to become functionally active, this linear chain has to assume a 
specific three-dimensional structure, called the native fold. In some cases, an additional 
level of complexity arises by the assembly of several molecules into a supramolecular 
quarternary structure. The necessary and sufficient information specifying the final three-
dimensional appearance of a protein is contained in its primary sequence (Anfinsen, 
1973; Dobson and Karplus, 1999).  
Many small proteins can fold spontaneously in vitro without the help of accessory 
factors (Hartl et al., 2011), but the in vivo situation is much more challenging. All cellular 
compartments contain proteins in high concentrations, a situation called molecular 
crowding (Ellis and Minton, 2006). This creates the danger of nonspecific protein-protein 
interactions of newly synthesized or misfolded polypeptide chains on their folding 
pathway (Ellis and Minton, 2006). Unfolded polypeptide chains can accumulate in 
kinetically trapped conformations. For further folding into a conformation with even 
lower free energy, trapped conformers have to overcome a free energy barrier. This step 
is presumably catalyzed by specialized folding helpers, called “molecular chaperones” 
(Bartlett and Radford, 2009; Hartl et al., 2011). In order to ensure correct protein folding 
and prevent the deleterious aggregation of unfolded or misfolded proteins, the cell 
engages an elaborate system of chaperones. In conjunction with proteases that degrade 
terminally misfolded proteins, chaperones constitute the cellular protein quality control 
network. 
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1.1.2 Protein quality control and homeostasis (proteostasis) 
For the health and stability of a cell or a multicellular organism, it is crucial that the 
quality of proteins is maintained at any time. Protein synthesis and degradation also needs 
to be balanced and adjusted to the prevailing environmental conditions (Chen et al., 
2011). Protein homeostasis (proteostasis) is accomplished by the concerted action of 
protein folding systems and proteolytic systems. They are known as the protein quality 
control network of the cell (Fig. 1). To a certain extent, these systems can adjust to 
changing internal or external requirements, thus allowing for a broader survivability of 
the cell. For instance, heat stress or oxidative stress causes increased unfolding and 
aggregation of proteins. In response, the cell can switch on transcription and translation of 
key components of the quality control system. In this way, the capacity of the quality 
control system is expanded for a short time. This control circuit is named the 
environmental stress response, after its underlying mechanism (Buchberger et al., 2010; 
Figure 1. The protein quality control network 
From bacteria to eukaryotes, the protein quality control system integrates a network of 
chaperones (see 1.2) for de novo folding of newly synthesized proteins, disaggregation and 
refolding of misfolded states and a degradation pathways combining specified proteases as 
the ubiquitin proteasome system and autophagy. Heat shock proteins (Hsps) represent the 
main class of chaperones whereas AAA proteases constitute the main players in 
degradation. (Modified from Hartl et al., 2011) 
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Voisine et al., 2010; Chen et al., 2011). 
In eukaryotic cells, quality control systems exist in the cytosol and in the 
organelles. The principle of the environmental stress response applies also to the 
membrane-enclosed organelles. Elaborate crosstalk must occur between the nucleus and 
the organelles to generate the organellar unfolded protein response (UPR). An organellar 
unfolded protein response has been described in the endoplasmic reticulum (Walter and 
Ron, 2011; Hetz, 2012) and recently also in mitochondria (UPRmt; mitochondrial UPR) 
(Zhao et al., 2002; Yoneda et al., 2004; Haynes and Ron, 2010). Furthermore, both 
organelles contain elaborate proteolytic systems that degrade that which can not be 
(re)folded. In the endoplasmic reticulum (ER), this system is named ERAD (ER-
associated degradation) (Romisch, 2005; Bukau et al., 2006).  
 
1.1.3 Failure of protein quality control and homeostasis 
The failure of protein quality control systems has severe consequences for the cell. In 
humans, the dysfunction of critical protein quality control components results in serious 
disorders, amongst them the neurodegenerative symptom complexes of Morbus 
Alzheimer, Morbus Parkinson and Chorea Huntington. The neuropathological hallmark 
of these diseases is the accumulation of toxic protein aggregates in specific cerebral areas. 
This causes cell death resulting in the characteristic clinical symptoms: dementia and 
movement disorders (Taylor et al., 2002; Stefani and Dobson, 2003). It is assumed that 
age-associated decline of the capacity of the protein quality control systems is the reason 
for the late onset of these typically age-dependent degenerative disorders. One of the 
major objectives for diagnosis and development of therapeutic treatments is to understand 
the underlying mechanisms of proteome maintenance (Chiti and Dobson, 2006; Leidhold 
and Voos, 2007; Balch et al., 2008; Hartl et al., 2011). 
 
1.2 Molecular chaperones 
 
Proteins that help other proteins to reach their native fold but which are not part of 
the mature three-dimensional structure themselves are called molecular chaperones (Hartl 
and Hayer-Hartl, 2009). All kingdoms of life contain complex systems of chaperones. 
Proteins of very different classes belong to the chaperone family. Heat shock proteins 
(Hsps) are the best known class of chaperones. Hsps were discovered as a class of 
proteins whose expression is upregulated upon heat shock. However, it subsequently 
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became clear that most heat shock proteins are actually ubiquitously expressed and some 
are not even upregulated upon cellular stresses (Nollen and Morimoto, 2002). Their 
functions range from de novo protein folding to refolding of denatured proteins, 
disaggregation of small aggregates, protein trafficking, and targeting of proteins to 
degradation (Powers et al., 2009; Hartl et al., 2011) (Fig.1). Usually, chaperones use 
repeated cycles of binding to and release from their substrates. This reaction cycle is 
regulated by ATP hydrolysis. The classical ATP-dependent chaperones belong to the 
Hsp70, Hsp60-Hsp10, Hsp90 and, Hsp100 systems. 
1.2.1 The Hsp70 system 
Members of the Hsp70 family exist in the cytosol of eubacteria (DnaK), in the 
cytosol of eukaryotes and in all major subcellular compartments of eukaryotic cells: the 
ER, chloroplasts and mitochondria (Misselwitz et al., 1998; Liu et al., 2001; Mayer and 
Bukau, 2005). Hsp70 proteins are highly abundant and have a conserved domain 
structure. The N-terminal nucleotide-binding domain of ∼ 44 kDa mediates ATP binding 
and hydrolysis. The C-terminal peptide binding domain of ∼ 27 kDa contains a β-
sandwich with the peptide binding cleft and an α-helical segment serving as a lid (Bukau 
and Horwich, 1998). Unfolded proteins are recognized by means of exposed hydrophobic 
amino acid side chains and bound in an extended conformation (Erbse et al., 2004; 
Mayer, 2010). 
The substrate affinity of Hsp70 proteins depends on the nucleotide state. In the 
ATP-bound state the affinity for the substrate is low whereas in the ADP-bound state the 
affinity is high. The intrinsic ATPase rate of Hsp70s is very low. Co-chaperones of the 
family of J domain proteins (Hsp40 family) are necessary to stimulate the ATPase 
activity of the Hsp70s and thus couple substrate binding to ATP hydrolysis (Rowley et 
al., 1994; Kampinga and Craig, 2010). 
ATP hydrolysis by the Hsp70s is accompanied by distinct conformational changes 
that characterize the transition from the low affinity state to the high affinity state. For 
release of the substrate, exchange of ADP by ATP is necessary. Binding of ATP also 
induces the transition back from the high affinity state to the low affinity state. This step 
is mediated by nucleotide exchange factors (Bolliger et al., 1994). 
 
1.2.2 The chaperonins 
Proteins that fail to assume their native three-dimensional structure with the help of 
Hsp70 chaperones (Heyrovska et al., 1998) interact with a downstream chaperone 
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system, the chaperonins of the Hsp60 family. Chaperonins are double-ring complexes of 
∼ 800 kDa forming a central cavity that can accommodate substrates of up to 60 kDa. 
This cavity shields the substrate protein from the surrounding. The principle of folding 
within a central cavity has the main advantage that substrate proteins are protected from 
the aberrant interactions and aggregation. Such incorrect interactions can easily occur due 
to the molecular crowding in the cell (Brinker et al., 2001). 
Chaperonins are subdivided into two classes. The group I chaperonins, called 
HSP60 in eukaryotes and GroEL in eubacteria, consist of seven subunits per ring and 
work hand in hand with HSP10 proteins (GroES in eubacteria). The best studied example 
of group I chaperonins is the bacterial GroEL-GroES system, whose folding cycle has 
been described in detail (Horwich and Fenton, 2009; Hartl et al., 2011). Hydrophobic 
stretches of the substrate bind to the apical part of the hydrophobic central cavity of one 
GroEL ring, the ‘cis’ ring. Binding of ATP to the cis ring induces conformational changes 
that enable binding of the GroES lid (Walter, 2002). The wall of the central cavity 
changes from a hydrophopic state to a hydrophilic state. Thus, the substrate is forced to 
bury its hydrophobic residues, which promotes folding. Moreover, substrates have a 
limited range of sterical freedom inside the cavity, and this also favors the formation of 
more compact and native-like structures (Chakraborty et al., 2010). The substrate remains 
in the cavity for approximately ten seconds (Xu et al., 1997; Hartl and Hayer-Hartl, 
2009). Subsequently, ATP hydrolysis in the cis ring and binding of unfolded polypeptide 
and ATP to the opposite ring (trans ring) trigger the release of GroES and the substrate 
(Horwich et al., 2006). Similar to folding assisted by HSP70, substrates that fail to fold 
during one ATP cycle of the chaperonin rebind and undergo another round of folding 
(Horwich et al., 2006; Hartl et al., 2011). 
Group II chaperonins (TRiC) exist only in the eukaryotic cytosol and are composed 
of eight paralog subunits (Frydman, 2001). Group II chaperonins do not cooperate with 
HSP10 proteins, but have a type of built-in lid that can close the central cavity upon 
substrate engagement (Douglas et al., 2011; Munoz et al., 2011). A recent study 
integrated chemical cross-linking, mass spectrometry and combinatorial modeling to 
determine the subunit arrangement of the TRiC complex (Leitner et al., 2012). 
 
1.2.3 The Hsp90 system 
Hsp90 proteins are highly conserved from eubacteria to mammals. Dimerization of 
two monomers is a prerequisite for functional activity. Each monomer is comprised of an 
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N-terminal nucleotide binding domain, a middle domain that is involved in ATP 
hydrolysis and substrate binding and a C-terminal dimerization domain. In contrast to the 
usually unfolded substrates of other chaperone systems, many Hsp90 substrates have a 
native or near-native state. 
ATP binding triggers the dimerization of two Hsp90 protomers. This leads to the 
formation of a ‘molecular clamp’ that can bind substrate proteins (Hessling et al., 2009; 
Hartl et al., 2011). The dimerization also induces hydrolysis of the bound ATP. However, 
the intrinsic ATPase rate of Hsp90 is low and largely modulated by a great number of co-
chaperones. The co-chaperones Hop/Sti1 and Cdc37 stabilize the open conformation of 
Hsp90 thus inhibiting ATP hydrolysis (Roe et al., 2004; Vaughan et al., 2006; Hessling et 
al., 2009). In contrast, co-chaperone Aha1 binds to the closed conformation and 
accelerates ATP hydrolysis. P23/Sba1 also binds to the closed conformation, however it 
inhibits ATP hydrolysis similar to Hop/Sti1 and Cdc37 (Roe et al., 2004). Furthermore, 
post-translational modifications such as phosphorylation or nitrosylation of amino acid 
residues in the hinge region between the middle domain and the dimerization domain 
modulate the ATPase activity of Hsp90 (Retzlaff et al., 2009; Mollapour et al., 2010). 
The co-chaperones Hop/Sti1, Cdc37 and p23/Sba1 also work as adaptor proteins for 
substrates of Hsp90.  
The substrate binds to Hsp90 in the open conformation. Subsequently, dimerization 
of the two Hsp90 monomers triggers release of the substrate (Mayer, 2010). The 
multitude of co-factors enables Hsp90 proteins to handle a large range of substrates and 
to fine-tune the HSP90 reaction cycle (Scheufler et al., 2000; Hartl et al., 2011).  
In eukaryotic cells, HSP90 occupies a branch point in numerous essential signaling 
pathways, amongst them cell cycle progression, apoptosis and innate immunity (Taipale 
et al., 2010). Hsp90 proteins have been suggested to promote evolution by buffering the 
effects of structurally destabilizing mutations, and thus allowing the generation of new 
variants of proteins (Rutherford and Lindquist, 1998). 
The functions of Trap1, the mitochondrial representative of the Hsp90 family, 
remain largely elusive. They do not seem to overlap with the functions of other Hsp90 
chaperones (Dollins et al., 2007; Frey et al., 2007; Leskovar et al., 2008) (Felts et al., 
2000). However, it was recently suggested that Trap1 helps to prevent the formation of 
reactive oxygen species (ROS) and ROS-induced apoptosis (Wandinger et al., 2008). 
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1.2.4 The Hsp100 system 
Hsp100 chaperones belong to the superfamily of AAA+ P-loop ATPases (ATPases 
associated with various cellular activities). All AAA+ proteins form homo-hexameric 
ring complexes (Neuwald et al., 1999; Ogura and Wilkinson, 2001; Lupas and Martin, 
2002) (see 1.3.1). Each subunit is comprised of one or two highly conserved AAA+ 
domains. The AAA+ domain is subdivided into a small and a large subdomain. AAA+ 
domains share the highly conserved Walker A and B motifs that are involved in 
nucleotide binding (Lupas and Martin, 2002). 
ClpB in E. coli and its homologs in plants (Hsp101) and lower eukaryotes (Hsp104) 
mediate disaggregation of protein aggregates by threading them through a central pore. 
Unfolded substrates are passed on to the Hsp70/Hsp40 system for new folding attempts 
(Ben-Zvi and Goloubinoff, 2001; Krzewska et al., 2001; Lee et al., 2004; Buchberger et 
al., 2010; Lotz et al., 2010; Richter et al., 2010). Indeed, Hsp100 chaperones not only 
deliver disaggregated proteins to the Hsp70/Hsp40 system, but also function in the 
recovery of damaged Hsp70 proteins after cellular stress (von Janowsky et al., 2005). 
Surprisingly, higher organisms lack the Hsp100 system, although an “unfoldase” 
activity has recently been reported (Bieschke et al., 2009; Murray et al., 2010). It is not 
yet clear how higher eukaryotes overcome the lack of this system. It has been speculated, 
however, that the Hsp70 system could have taken over the functions of the Hsp100 
system (Ben-Zvi and Goloubinoff, 2001). Indeed, it has recently been shown that the 
human Hsp70 protein mortalin can mediate disaggregation and thus compensate for the 
lack of Hsp100 chaperones (Iosefson et al., 2012). 
Several representatives of the Hsp100 chaperone family (ClpA, ClpX, HslU in E. 
coli) associate with ring-shaped compartmental peptidases (ClpP, HslV), which will be 
discussed in detail in 1.3.3.  
 
1.3 Proteolytic systems 
 
1.3.1 The AAA protein family 
Proteases involved in protein quality control provide the ‘last resort’ for terminally 
damaged proteins that fail to refold and thus constitute a high risk for the cell (Pickart and 
Cohen, 2004). All thus-far identified proteases that are involved in protein degradation 
belong to the AAA family of P-loop NTPases. Besides their role in protein degradation, 
these enzymes occupy hub positions in a multitude of other cellular processes such as 
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mitosis, meiosis, membrane fusion and transport, and DNA replication (Ogura and 
Wilkinson, 2001). 
AAA proteins consist of six or seven subunits forming large ring shaped structures. 
Each subunit contains one (type I ATPase) or two (type II ATPase) typical AAA domains 
of approximately 230 amino acids (Kunau et al., 1993; Sauer and Baker, 2011; Langklotz 
et al., 2012). The highly conserved Walker A and Walker B motifs of the AAA domain 
are involved in ATP binding and hydrolysis. A conserved lysine residue within the P-loop 
of the Walker A motif is essential for ATP binding (Neuwald et al., 1999). Mutation of 
this lysine residue prevents nucleotide binding and thus inactivates the AAA protein 
(Walker et al., 1982a; Iyer and Aravind, 2004). An aspartate residue within the Walker B 
motif coordinates a magnesium ion that is essential for ATP hydrolysis (Iyer et al., 2004; 
Hanson and Whiteheart, 2005).  
AAA proteins represent a subfamily of the AAA+ proteins and share some 
characteristic structural features, distinguishing them from other AAA+ family members. 
The most prominent of these features is the second region of homology (SRH) (Lupas 
and Martin, 2002; Frickey and Lupas, 2004) present at the C-terminal part of the AAA 
domain. Two conserved arginine residues of the second region of homology are involved 
in ATP hydrolysis and in mediating conformational changes between neighboring 
subunits (Karata et al., 1999; Ogura et al., 2004). 
 
1.3.1 The AAA protease family 
The AAA protease family also belongs to the superfamily of AAA+ proteins. AAA 
proteases combine proteolytic and ATPase function. Proteolytic and AAA activities can 
be located on the same or on different polypeptide chains. LON and FtsH proteases 
contain both activities on one polypeptide chain whereas ClpP proteases associate with 
separate AAA proteins to form the functional enzyme complex. Each protease family 
contains specific auxiliary domains that often serve as docking sites for adaptor proteins. 
In case of FtsH, this “extra” domain anchors the protease to the membrane (Ito and 
Akiyama, 2005). 
The proteolytic sites of AAA proteases are face an “inner chamber” (Tyedmers et 
al., 2010; Sauer and Baker, 2011; Voos, 2012) and the enzymes are thus designated 
‘chambered’ or ‘compartmental’ proteases (Bieniossek et al., 2006; Suno et al., 2006). 
The diameter of the chamber is rather small and thus only unfolded polypeptides are able 
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to enter it. The ATPase activity unfolds the substrates and threads them into the 
proteolytic chamber. 
The unfolding mechanism on the molecular level has been investigated in detail for 
the bacterial enzyme ClpXP (see 1.3.3). Nucleotide binding to one subunit of the homo-
hexamer leads to a rotation between large and small AAA subdomains and this movement 
is propagated to the neighboring subunit (Lupas and Martin, 2002). ATP hydrolysis 
drives rigid body movements of the entire AAA ring that are carried forward to the highly 
conserved central substrate binding loops in the with the GYVG motif. These loops ‘roll’ 
from an up position to a down position and thereby translocate the polypeptide chain 
through the central pore (Hanson and Whiteheart, 2005).  
Proteolysis is an irreversible process, and therefore it is strictly controlled. 
Substrates for degradation are usually marked with specific degradation signals, also 
designated degradation tags or degrons (Sauer and Baker, 2011). Proteins that are 
targeted for proteasomal degradation contain bipartite degrons. Such degrons consist of a 
proteasome binding signal and a degradation initation site. 
The major subfamilies of AAA proteases are the LON, Clp and FtsH proteases. 
They are named after their prokaryotic representatives whose structures, functions and 
working mechanisms are known in detail. 
 
1.3.2 LON proteases 
LON proteases are soluble representatives of the AAA protease family (Schmidt et 
al., 2009a). They are highly conserved and can be found in the cytosol of eubacteria and 
in the mitochondrial matrix of eukaryotic cells. LON proteases consist of an N-terminal 
substrate binding domain, an ATP-binding domain and a C-terminal proteolytic domain 
(Cha et al., 2010). Therefore, LON proteases contain proteolytic and ATPase activities on 
a single polypeptide chain. Because they harbor a catalytic lysine-serine diad, LON 
proteases belong to the class of serine proteases. 
LON proteases are essential for the removal of misfolded and oxidatively damaged 
proteins (Goldberg and Waxman, 1985; Suzuki et al., 1994; Bota et al., 2002; Botos et 
al., 2004). The bacterial LON protease mediates approximately half of all protein 
degradation (Ondrovicova et al., 2005; von Janowsky et al., 2005); (Gur and Sauer, 
2008). LON substrates carry stretches of hydrophobic amino acid residues that would 
usually be buried in the native fold of the protein. These residues function as degradation 
tags for recognition by LON. 
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Notably, a decrease in the concentration of LON protease in human cells causes 
defects in the mitochondrial morphology and an increased rate of apoptosis. This 
emphasizes the fact that an intact proteolytic system is essential for overall survival of the 
cell (Bota et al., 2002; Bota et al., 2005). 
 
1.3.3 ClpP proteases 
ClpP proteases constitute a second class of soluble proteases. They belong to the 
family of caseinolytic proteases and harbor a characteristic histidine-aspartate-serine 
catalytic triad. ClpP consists of two homo-heptameric rings where the proteolytic sites are 
facing an inner tunnel (Kang et al., 2002; Kang et al., 2005; Sauer and Baker, 2011). 
Distinct from LON proteases, the ATPase activity is not encoded on the same polypeptide 
chain, and thus ClpP assembles with a homo-hexameric AAA chaperone ring that in turn 
functions in the recognition of substrates, unfolding, and translocation of the unfolded 
polypeptide chain into the proteolytic chamber (Kang et al., 2002). Three different 
partner chaperones are known in bacteria - ClpX, ClpA and ClpC (Baker and Sauer, 
2012). ClpA and ClpC contain two AAA domains that seem to function independently as 
protein unfoldases. However, the biological reason for the presence of two AAA domains 
is not yet understood (Kress et al., 2009).  
Additional factors function as adaptors and target substrate proteins for degradation 
by binding simultaneously to the substrate and ClpP (Baker and Sauer, 2012). The 
dimeric adaptor protein SspB targets ssrA-tagged (11-amino acid tail) proteins to ClpXP 
(Levchenko et al., 2000; Flynn et al., 2004; Lies and Maurizi, 2008). The monomeric 
adaptor protein ClpS contains a specific binding pocket for ‘N-end rule’ residues and 
targets such substrates to ClpAP (Dougan et al., 2002; Erbse et al., 2006; Mogk et al., 
2007; Schmidt et al., 2009b). 
Further important representatives of the ClpP protease family are the eukaryotic 
26S proteasome, the archeal PAN proteasome, and the prokaryotic 20S proteasome 
(Striebel et al., 2009; Sauer and Baker, 2011). These supermolecular complexes have a 
modular construction principle that allows for variation in the assembly. The proteolytic 
core is composed of four stacked rings of ClpP proteases. The proteolytic unit is capped 
by AAA chaperone rings on both sides. All active proteolytic sites are concentrated in the 
central cavity, and therefore the substrate can be degraded by multiple proteolytic sites at 
the same time (Sauer and Baker, 2011). 
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The substrate recognition process is best investigated for the eukaryotic 26S 
proteasome. Specific enzymes (E1, E2, E3) transfer and activate polyubiquitin tags on the 
substrate protein (Elsasser and Finley, 2005). These tags are then recognized by receptor 
proteins of the proteasome. Only recently, the intrinsic ubiquitin receptor Rpn13 that 
mediates recognition of polyubiquitinated substrates by the proteasome in cooperation 
with adaptor proteins was identified (Husnjak et al., 2008). In addition to the 
polyubiquitin tag, degradation by the 26S proteasome depends on an unstructured 
initiation site in the substrate protein as a starting point for unfolding and degradation. 
26S proteasomes are present in the nucleus and the cytosol, where a subgroup is 
associated with the ER mediating ER-associated degradation (Smith et al., 2011). 
Recently, a similar ubiquitin-like tagging system has been identified in bacteria. 
Substrates are labeled for degradation by transfer of the small conserved protein Pup, 
similar to ubiquitinylation in eukaryotes (Pearce et al., 2008). Substrate recruitment and 
recognition mechanisms of the bacterial 20S proteasome are, however, not yet well 
understood (Striebel et al., 2009). 
 
1.3.4 FtsH proteases 
In contrast to LON and ClpP proteases, the AAA family of FtsH proteases is 
anchored to the membrane by its auxiliary domain (Karata et al., 2001). The protein 
family is named after the eubacterial representative FtsH. In cooperation with LON 
protease, FtsH mediates the degradation of unfolded ssrA-tagged proteins. However, its 
main task is the protein quality control of membrane proteins (Langklotz et al., 2012). 
The interactome of bacterial FtsH comprises HtpX, an ATP-independent 
endopeptidase that has overlapping substrate specifity with FtsH (Sakoh et al., 2005) and 
the prohibitin-like proteins HflK and QmcA (Chiba et al., 2006). HflK and QmcA 
regulate the activity of FtsH. FtsH-like proteases are also found in the membranes of 
eukaryotic mitochondria or chloroplasts. The two mitochondrial representatives in yeast 
are located in the inner mitochondrial membrane and will be discussed in detail in 1.6. 
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1.4 Mitochondrial biogenesis 
 
1.4.1 Mitochondrial subcompartmentalization 
Mitochondria are highly complex organelles descending from a bacterial ancestor 
that was engulfed by the progenitor of a eukaryotic cell (Gray, 1999). For this reason, 
mitochondria are delineated by two lipid bilayers, the inner and the outer mitochondrial 
membrane. These membranes define two aqueous compartments, the intermembrane 
space and the innermost matrix (Palade, 1953). A number of essential cellular processes 
take place in mitochondria: the tricarboxylic acid cycle (TCA cycle) (Shadel, 2005), 
heme biosynthesis, iron-sulfur cluster assembly (Lill et al., 2012), β-oxidation of fatty 
acids, metabolism of certain amino acids and oxidative phosphorylation to mention only a 
few. Oxidative phosphorylation converts the nutrient-derived energy into the energy 
carrier molecule ATP that can be utilized by the cell (Dudkina et al., 2010; Nunnari and 
Suomalainen, 2012). An elaborate set of mitochondrial proteins regulate the 
morphological dynamics of the organelle (Shaw and Nunnari, 2002). Furthermore, 
mitochondria also play a key role in apoptosis. They stimulate the intrinsic cell death 
pathway by release of several pro-apoptotic factors from the mitochondrial 
intermembrane space (Youle and van der Bliek, 2012). Given the multitude of molecular 
players involved in these essential processes, an intricate control system is needed to 
ensure protein quality control and homeostasis.  
Remniniscent of their bacterial origin, mitochondria still contain their own genome. 
The mitochondrial DNA resides in the matrix and encodes only a few proteins (e.g. 8 in 
S. cerevisiae, 13 in H. sapiens, and 25 in A. thaliana) (Reichert and Neupert, 2004). The 
vast majority of mitochondrial proteins are, however, encoded in the nucleus and 
translated on cytosolic ribosomes. Newly synthesized mitochondrial proteins have to be 
translocated across one or two mitochondrial membranes and sorted to one of the four 
subcompartments. In order to achieve this task, an elaborate system of protein 
translocases that recognize, translocate and sort mitochondrial proteins has evolved to 
guide these transport processes (Mokranjac and Neupert, 2008; Chacinska et al., 2009; 
Becker et al., 2012). Mitochondrial protein translocases only allow transport of largely, if 
not completely, unfolded proteins. 
1.4.2 Mitochondrial protein import 
Nuclear-encoded mitochondrial proteins are translated as precursor proteins 
harboring specific mitochondrial targeting signals. These targeting signals contain all the 
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information that is necessary and sufficient to target the proteins to the correct 
submitochondrial compartment. The first known targeting signals are the N-terminal 
matrix-targeting signals (Neupert and Herrmann, 2007; Mokranjac and Neupert, 2008). 
The matrix-targeting signals are not conserved in their primary sequence but they all have 
the potential to form amphipathic helices with one positively charged and one 
hydrophobic side. The matrix-targeting signal is necessary and sufficient to target the 
precursor proteins to the mitochondrial matrix where the targeting signal is cleaved off by 
mitochondrial processing peptidase (Arretz et al., 1991). During the last years, it has 
become clear that in addition to the N-terminal matrix-targeting signals, a multitude of 
further targeting signals exist. These involve in particular internal targeting signals that 
are not cleaved off after import. Most of them are still poorly characterized and it is 
conceivable that many more will still be found. 
The TOM (translocase of the mitochondrial outer membrane) complex forms the 
major import pore of the outer membrane (Neupert and Herrmann, 2007; Endo and 
Yamano, 2009) (Fig. 2). The receptor components of the TOM complex recognize 
mitochondrial precursor proteins by their targeting signals. The TOM complex alone is 
sufficient for the transport of a subset of outer membrane proteins and some 
intermembrane space proteins. Transport of all other proteins depends on the concerted 
action of TOM and additional mitochondrial translocases.  
β-barrel proteins of the outer membrane are passed to by the small TIM (translocase 
of the mitochondrial inner membrane) complexes when they emerge from the TOM 
complex (Koehler, 2004b). The small TIM complexes escort the β-barrel proteins through 
the intermembrane space to the TOB/SAM (topogenesis of outer membrane β-barrel 
proteins/ sorting and assembly machinery) complex in the outer membrane. TOB/SAM 
mediates the insertion of the β-barrel proteins into the outer membrane (Kozjak et al., 
2003; Paschen et al., 2003; Wiedemann et al., 2003).  
Only recently, a further system that inserts proteins into the outer membrane was 
detected. Mim1 and Mim2, two integral outer membrane proteins, mediate the insertion 
of some single-span, and all known multi-span, outer membrane proteins (Becker et al., 
2008). Mim1 and Mim2 interact in the outer membrane to form the MIM (mitochondrial 
import) complex (Dimmer et al., 2012). MIM mediates the insertion of many components 
of the TOM complex into the outer membrane and probably also promotes assembly of 
the TOM complex (Dimmer and Rapaport, 2010).  
For import of a subset of small proteins that contain conserved cysteine residues 
in the form of CX3C or CX9C motifs, TOM cooperates with the Mia-Erv disulfide relay 
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system of the intermembrane space. This recently discovered import system introduces 
disulfide bonds into its substrates (Stojanovski et al., 2008; Deponte and Hell, 2009; 
Koehler and Tienson, 2009; Herrmann and Riemer, 2012). It is assumed that the 
introduction of disulfide bonds promotes folding of the entire substrate protein. 
Immediate folding after translocation through TOM complex also prevents retrograde 
translocation. Thus, transport through the TOM complex becomes uni-directional. 
A similar folding trap mechanism was also observed for a group of Mia-Erv-
independent intermembrane space proteins. Apo-cytochrome is translocated through the 
TOM complex and assumes its mature fold upon addition of a heme group in the 
intermembrane space (Dumont et al., 1991). Sod1 also folds in the intermembrane space 
upon formation of a disulfide bond by Ccs1 (Field et al., 2003).  
Figure 2. Protein import into mitochondria 
Nuclear-encoded proteins with mitochondrial destination are translocated through the 
outer membrane (OM) by TOM complex. Small TIM complexes escort outer membrane 
proteins for insertion to the TOB complex in the OM, and members of the carrier family to 
TIM22 complex in the inner membrane (IM). A subset of IMS proteins is trapped in the 
intermembrane space (IMS) by introduction of disulfide bonds by the Mia-Erv disulfide 
relay system. Precursors carrying a matrix-targeting signal (MTS) are passed from the 
TOM complex to TIM23 in the inner membrane, which mediates translocation across the 
inner membrane or lateral insertion of precursors with an additional stop-transfer signal 
into the lipid bilayer. The OXA1 complex of the inner membrane mediates co-translational 
insertion of proteins encoded in the mitochondrial genome into the inner membrane. 
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Members of the carrier family of inner membrane proteins contain multiple 
transmembrane domains and are thus very hydrophobic. At the exit of the TOM complex 
they are received by the small TIM complexes. The small TIM complexes shield the 
hydrophobic segments of the carrier proteins and guide them to the TIM22 complex of 
the mitochondrial inner membrane. TIM22 promotes membrane potential-dependent 
insertion of carrier proteins into the inner membrane (Rehling et al., 2003; Koehler, 
2004a).  
However, the majoritiy of mitochondrial precursors follow the main import 
pathway through the TOM complex in the outer membrane and the TIM23 complex in 
the inner membrane. The TIM23 translocase can work in two functional modes, for 
insertion of precursor proteins into the inner membrane on the one hand, and for 
translocation of precursor proteins into the matrix on the other hand (Mokranjac and 
Neupert, 2010; Marom et al., 2011). Most precursor proteins of this pathway carry N-
terminal matrix-targeting signals that are cleaved off by the mitochondrial processing 
peptidase in the matrix. Membrane potential is needed for translocation of the matrix-
targeting signal across the inner membrane. For translocation of the mature part of 
precursor proteins, the membrane potential is not sufficient. The ATP-dependent import 
motor of TIM23 provides the driving force for import of the mature part of the precursor 
protein into the matrix (Neupert and Brunner, 2002). Precursors that are targeted to the 
inner membrane contain hydrophobic stop-transfer signals downstream of the matrix-
targeting signal. The stop-transfer signal induces lateral opening of the TIM23 complex 
and release into the lipid bilayer of the inner membrane. These proteins can then either 
stay anchored in the inner membrane by their transmembrane domain or undergo a 
second cleavage at the level of the inner membrane. Proteins that are cleaved twice are 
released as soluble proteins into the intermembrane space.  
Some inner membrane proteins use an alternative sorting pathway to reach the inner 
membrane. They enter the matrix through the TIM23 complex and are then sorted back 
into the inner membrane by the OXA1 complex of the inner membrane. This pathway is 
referred to as the conservative sorting pathway as it is apparently inherited from gram-
negative bacteria, the endosymbiontic ancestors of mitochondria. Recent evidence 
suggests that the lateral insertion and conservative sorting pathways can cooperate for 
insertion of multitopic inner membrane proteins (Bohnert et al., 2010).  
The OXA1 complex handles yet another set of proteins, namely those that are 
encoded in the mitochondrial DNA (Herrmann and Neupert, 2003; Mokranjac and 
Neupert, 2009). Proteins that are encoded in the mitochondrial genome are translocated in 
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a co-translational manner. It is assumed that the main driving force for membrane 
insertion is provided by the mitochondrial ribosome that pushes the nascent polypeptide 
chain into the OXA1 translocase (Herrmann and Neupert, 2000). 
 
1.5 Mitochondrial protein quality control 
 
Almost all mitochondrial proteins have to cross one or two membranes in order to 
reach their destination. Translocases transport only largely unfolded proteins and 
therefore folding can only occur at the compartment of destination. For this purpose, 
intrinsic mitochondrial folding systems have evolved. The inner mitochondrial membrane 
and the matrix are also not accessible to the cytosolic protein quality control systems. 
Thus, not only intrinsic folding systems but also intrinsic quality control systems are 
needed in the diverse mitochondrial subcompartments (Baker and Haynes, 2011). Intact 
mitochondria are crucial for the integrity of the whole cell, and mitochondrial dysfunction 
correlates with aging and the onset of a multitude of neurodegenerative diseases (Rugarli 
and Langer, 2006; Hartl et al., 2011). This emphasizes that a functional mitochondrial 
protein quality control system is essential for cell survival. 
Elaborate and complex systems of mitochondrial chaperones and proteases represent 
the first level of mitochondrial quality control. The second level of mitochondrial quality 
control is based on mitochondrial dynamics (Hoppins et al., 2007; Otera and Mihara, 
2011). Mitochondrial fusion enables exchange of intact components between 
mitochondria, whereas mitochondrial fission can separate severely damaged 
mitochondrial areas. Such areas are subsequently removed by mitophagy, thus preventing 
a toxic effect of terminally damaged mitochondria on still intact neighboring 
mitochondria (Tanaka et al., 2010; Wang and Klionsky, 2011; Youle and Narendra, 
2011). The largest effects are conveyed by apoptosis, the third level of quality control. In 
the case of extensive cellular damage that overwhelms the first two levels of protein 
quality control, mitochondria can trigger the intrinsic apoptosis pathway by release of 
pro-apoptotic factors from the mitochondrial intermembrane space (Wasilewski and 
Scorrano, 2009; Martin, 2010). The following paragraphs will focus on the first level of 
mitochondrial protein quality control and discuss the principles of the most important 
systems. 
  
	   	   INTRODUCTION	  
 
	   23	  
1.5.1 Protein quality control in the mitochondrial outer membrane 
Proteins of the outer mitochondrial membrane are degraded by cytosolic proteasomes 
in a process named outer mitochondrial membrane associated degradation (OMMAD) 
(Neutzner et al., 2007) similar to ER-associated degradation (ERAD) (Smith et al., 2011). 
We have only recently begun to identify the molecular factors that are involved in 
OMMAD has started. In mammalian cells, the E3 ubiquitin ligase Parkin transfers a poly-
ubiquitin tag to outer membrane proteins such as mitofusins that are involved in 
mitochondrial fusion. A cytosolic AAA protease (Cdc48/p97/Vcp), also involved in ER-
associated degradation, extracts ubiquitinated outer membrane proteins and transfers 
them to cytosolic proteasomes. 
 
1.5.2 Protein quality control in the mitochondrial matrix 
A set of “classical” chaperones and proteases ensures protein quality control in the 
mitochondrial matrix (Fig. 3). They represent the homologs of their cytosolic 
counterparts. Mitochondrial Hsp70, Ssc1, is involved in the import of newly incoming 
polypeptides and subsequently assists in their folding (Matouschek et al., 2000; Neupert 
and Herrmann, 2007). The distinction between the two functional modes of Ssc1 is 
mediated by Hsp40/DnaJ co-chaperones (Horst et al., 1997). Tim14-Tim16 complex 
(D'Silva et al., 2003; Mokranjac et al., 2007) is the main regulator of the intrinsic ATPase 
activity of Ssc1 within the TIM23 complex, whereas Mdj1 regulates the ATPase activity 
of Ssc1 during the folding of proteins in the matrix. Mge1 serves as a nucleotide 
exchange factor in both functional modes (Voos and Rottgers, 2002).  
Yeast mitochondria express three types of Hsp70s. Ssc1 is the most abundant, 
assisting translocation and folding processes, Ssq1 is involved in the assembly of iron-
sulfur clusters (Schilke et al., 1999) and the third representative is the largely 
uncharacterized Ssc3 (Baumann et al., 2000). Notably, mutations in mortalin, the human 
mitochondrial Hsp70, have recently been suggested to play an important role in the 
generation of diverse diseases such as cancer and age-related neuropathies (Yaguchi et 
al., 2007).  
Polypeptide chains that fail to assume their native three-dimensional structures with 
the help of Ssc1 are passed on to the Hsp60-Hsp10 system (Fig. 3) (see 1.2.2). Substrate 
proteins can undergo folding inside the interior cavity of Hsp60 (Hartl, 1995; Mayer, 
2010). Proteins that fail to fold in this process or get unfolded or damaged at a later time 
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point of their life have a high tendency to aggregate. Such misfolded proteins and 
aggregates represent a high risk for mitochondrial functionality.  
A matrix-located protease system can remove such terminally damaged proteins. 
Pim1, a member of the LON family of AAA proteases (see 1.3.2), degrades misfolded or 
otherwise damaged soluble matrix proteins (Bender et al., 2011; Wagner et al., 1994) 
(Fig. 3). Pim1 receives its substrates from Hsp70 and Hsp60 chaperone systems. Hsp70 
and Hsp60 promote degradation of folding-resistant substrates by Pim1. It is, however, 
still unclear how the chaperones ‘decide’ whether a unfolded substrate undergoes another 
round of folding or is targeted for degradation (Chen et al., 2011). Hsp78, a member of 
the ClpB/Hsp100 family (see 1.2.4), functions as a disaggregase. It contains a AAA+ 
domain, thus belonging to the AAA+ superfamily. In contrast to the Clp family of AAA 
Figure 3. Protein quality control systems of mitochondrial matrix and IMS 
Mitochondrial Hsp70, Ssc1, is involved in the import and subsequent folding of newly 
incoming precursor proteins. Downstream of Ssc1, the Hsp60-Hsp10 complex provides a 
shielded inner cavity for folding. Misfolded proteins are extracted from aggregates by the 
Hsp78 unfoldase and passed on to Ssc1 or Hsp60-Hsp10 for renewed folding. Terminally 
damaged proteins are degraded by the soluble AAA+ protease Pim1. Degradation of inner 
membrane proteins is accomplished by the concerted action of two membrane anchored 
AAA+ proteases: i- and m-AAA protease. 
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ATPases, Hsp78 unfolds proteins and passes them on to Hsp70 or Hsp60 for refolding or 
to proteases for degradation (Schmitt et al., 1995; Rottgers et al., 2002). 
 
1.5.3 Protein quality control in the mitochondrial inner membrane 
Two membrane-anchored proteases of the AAA family, the i-AAA and m-AAA 
protease (see 1.3.1) are involved in degradation of proteins at the levels of the inner 
membrane (Fig. 3). The catalytic domains of i-AAA and m-AAA protease face the 
intermembrane space and the matrix, respectively (Koppen and Langer, 2007; Tatsuta and 
Langer, 2009). Both were shown to be involved in the degradation of non-assembled 
proteins that are peripherally associated to, or integrated into, the inner mitochondrial 
membrane (Arlt et al., 1996; Leonhard et al., 1996; Korbel et al., 2004). i-AAA and m-
AAA protease have overlapping substrate specificity, and it was suggested that substrate 
discrimination occurs only on the basis of the opposing orientation of the two proteases in 
the inner membrane. 
 
1.5.4 Protein quality control in the mitochondrial intermembrane space 
In the mitochondrial intermembrane space, no members of the classical chaperone 
families are known. Obviously, atypical folding helpers could exist, but for most 
intermembrane space proteins it is not clear how they assume their mature fold. In 
comparison to the volume of the mitochondrial matrix, the intermembrane space 
constitutes a relatively small compartment. However, the integrity of the proteome of the 
intermembrane space is highly important. Such essential processes as the exchange of 
diverse ions and metabolites and oxidative phosphorylation depend on an intact proteome 
of the intermembrane space. Furthermore, in higher eukaryotes, the release of the 
intermembrane space protein cytochrome c triggers the caspase cascade inducing 
apoptosis. Therefore, in order to maintain proteostasis in the intermembrane space, 
appropriate quality control mechanisms must exist in this compartment. However, the key 
factors and mechanisms that are involved still remain largely elusive (Herrmann and Hell, 
2005; Neupert and Herrmann, 2007). 
Only recently, the above-mentioned Mia-Erv disulfide relay system was discovered 
and shown to mediate vectorial movement of proteins containing conserved cysteine 
residues across the outer membrane. For some of the rather small Mia-Erv substrates, it 
has been shown that introduction of disulfide bonds by Mia40 is sufficient to trigger 
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folding of the entire polypeptide chain (Hell, 2008; Koehler and Tienson, 2009; Sideris 
and Tokatlidis, 2010; Herrmann and Riemer, 2012). 
A similar folding trap mechanism has been observed for another group of 
intermembrane space proteins. Cytochrome c, for instance, is imported through the TOM 
complex as an apo-protein. It assumes its mature fold upon addition of a heme group by 
cytochrome c heme lyase (Dumont et al., 1991). Similarly, Sod1 assumes its mature fold 
upon introduction of a disulfide bond and Cu2+ by Ccs1 (Field et al., 2003). Thus, for a 
subset of intermembrane space proteins, addition of a cofactor or introduction of disulfide 
bonds seems to be sufficient to trigger folding of the entire protein. For all other 
intermembrane space proteins, amongst them very large ones with a complex structure, 
the folding process remains unknown. Neither folding helpers nor energy sources are 
known. 
The i-AAA protease Yme1 of the mitochondrial inner membrane belongs to the 
AAA protease family (see 1.3.1). Yme1 exposes its catalytic domain into the 
intermembrane space (Koppen and Langer, 2007; Baker et al., 2011) and was shown to 
mediate ATP-dependent degradation of intermembrane space and inner membrane 
proteins (Leonhard et al., 1996; Leonhard et al., 2000). Several endogenous substrates of 
the proteolytic activity of Yme1 were identified recently (Weber et al., 1996; Leonhard et 
al., 2000; Kominsky et al., 2002; Dunn et al., 2006; Graef et al., 2007; Potting et al., 
2010; Elliott et al., 2011). Already thirteen years ago, Yme1 was suggested to exert a 
chaperone-like activity. Its isolated AAA domain has been shown to refold denatured 
model substrates in vitro (Leonhard et al., 1999). However, in vivo evidence for a 
chaperone-like activity of Yme1 is so far lacking. 
 
1.6 Mitochondrial m-and i-AAA protease 
m- and i-AAA protease, the two AAA proteases of the inner mitochondrial 
membrane, share the conserved domain structure of AAA proteases (Fig. 4). The N-
terminal regions harbor one (i-AAA) or two (m-AAA) transmembrane segments. The 
AAA domain contains two conserved motifs, the nucleotide-binding Walker A motif 
(GXXXXGKS/T) and the magnesium-binding Walker B motif (XhXhXhXhDEXX) 
(Walker et al., 1982b; Lupas et al., 1997). Furthermore, the AAA domain contains the so-
called second region of homology (SRH) (Beyer, 1997; Patel and Latterich, 1998; Ogura 
and Wilkinson, 2001). SRH is essential for ATP hydrolysis and mediates the contact 
between two neighboring subunits in the hexamer (Karata et al., 1999; Karata et al., 
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2001; Ogura et al., 2004). The AAA domain is followed by a proteolytic domain of the 
M41 thermolysin metalloprotease family. The proteolytic domain contains a conserved 
zinc binding HEXGH consensus motif (Rawlings and Barrett, 1995). 
In yeast, the deletion of i- or m-AAA protease induces an elevated rate of 
mitochondrial DNA escape to the nucleus (Thorsness and Fox, 1993). The deletion 
strains are respiratory deficient although this defect is not due to the mitochondrial DNA 
escape. These strains show a significant growth defect on non-fermentable medium at 
high temperatures and on fermentable medium at low temperatures (Campbell et al., 
1994; Weber et al., 1996). Moreover, the deletions strains are ‘petite negative’ and 
Figure 4. Mitochondrial i- and m-AAA+ protease 
A) i- and m-AAA protease show the typical domain structure of the family of AAA+ 
proteases, with an N-terminal AAA+ motif including Walker A and B motifs (WA, WB) 
and the second region of homology (SRH), and a C-terminal proteolytic domain (PD) of 
the thermolysin family carrying the conserved proteolytic HEXGH motif. B) The catalytic 
domains of i- and m-AAA proteases face the IMS and the matrix, respectively. The 
potential adaptor proteins Mgr1 and Mgr3 are found in a supercomplex with the i-AAA 
protease, whereas m-AAA protease forms a supercomplex with prohibitins 1 and 2 
(Phb1/2). MTS, matrix-targeting signal; TM, transmembrane domain; NH, N-terminal 
helices; CH, C-terminal helices. Modified from Koppen and Langer, 2007. 
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therefore cannot grow without mitochondrial DNA, in contrast to wild-type S. cerevisiae 
strains (Thorsness and Fox, 1993; Campbell et al., 1994). Early electron microscope 
studies revealed that the deletion strains have altered mitochondrial architecture. The 
typical mitochondrial network is destroyed, mitochondria are grossly swollen and located 
in close proximity to vacuoles (Campbell et al., 1994; Campbell and Thorsness, 1998). 
This might be due to an increased turnover of mitochondria in the deletion strains, 
although evidence for this notion is lacking. The double deletion of both AAA proteases 
is lethal, thus emphasizing the overlapping substrate specificity of the two proteases. 
The yeast m-AAA protease consists of two alternating subunits, Yta10 and Yta12. 
Three Yta10 and three Yta12 subunits form a hetero-hexameric ring structure of 
approximately 1000 kDa (Arlt et al., 1996) (Fig. 4). Yta10 and Yta12 are homologs and 
share 53 % sequence identity. The m-AAA protease is helps mediate several regulatory 
steps during mitochondrial biogenesis (Esser et al., 2002; Tatsuta et al., 2007). In 
addition to the turnover of misfolded and damaged proteins, m-AAA protease functions 
as a processing peptidase. It cleaves the mitochondrial ribosome protein MrpL32, which 
is a crucial step for integration of MrpL32 into the mitochondrial ribosome (Nolden et al., 
2005). Furthermore, m-AAA protease functions as a membrane dislocase in the 
maturation process of Ccp1. The m-AAA-dependent dislocation of Ccp1 from the 
membrane is the prerequisite for processing of Ccp1 by rhomboid protease Pcp1 (Esser et 
al., 2002; Tatsuta et al., 2007). Recently, m-AAA protease was found in a supercomplex 
with prohibitins, protein and lipid scaffolds of the inner membrane (Steglich et al., 1999). 
Two homologous membrane-anchored proteins, Phb1 and Phb2, have been identified in 
all eukaryotic genomes (Berger and Yaffe, 1998). Based on their deletion phenotypes, it 
is likely that Phb1 and Phb2 exert a regulatory function during protein turnover by m-
AAA protease (Steglich et al., 1999; Nijtmans et al., 2000; Langer et al., 2001). 
The importance of an intact m-AAA protease is underlined by the finding that 
mutations in the genes encoding paraplegin or Afg3l2, the two subunits of mouse m-AAA 
protease, cause two severe neurological diseases: hereditary spastic paraplegia and 
spinocerebellar ataxia (Rugarli and Langer, 2006; Martinelli et al., 2009; Tatsuta and 
Langer, 2009). 
The mitochondrial i-AAA protease consists of six Yme1 subunits that form a homo-
hexameric ring structure similar to the m-AAA protease. Yme1 is anchored to the inner 
membrane by one transmembrane domain in the N-terminal segment and exposes its 
catalytic domains to the intermembrane space (Koppen and Langer, 2007; Gerdes et al., 
2012) (Fig. 4). Distinct from the m-AAA protease, no dislocation or processing activities 
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of Yme1 have been reported so far. However, several endogenous substrates of the 
proteolytic activity of Yme1 have been identified during the last few years.  
Cox2 and Nde1 are the first proteolytic substrates of Yme1 that were confirmed by in 
vivo studies (Nakai et al., 1995; Pearce and Sherman, 1995; Weber et al., 1995; Lemaire 
et al., 2000; Kominsky et al., 2002; Augustin et al., 2005; Graef et al., 2007). Nde1 is a 
soluble protein residing in the mitochondrial intermembrane space, providing NADH for 
the respiratory chain (Luttik et al., 1998). Cox2 is encoded in the mitochondrial genome 
(Cooper et al., 1991), and is the terminal member of the electron transport chain in the 
inner mitochondrial membrane. Hence, the localization of both verified Yme1 substrates 
is compatible with an the localization of the catalytic sites of Yme1. Recently, Ups1 and 
Ups2, two intermembrane space proteins that are involved in lipid metabolism, were 
shown to be degraded by Yme1 (Osman et al., 2009a; Tamura et al., 2009; Potting et al., 
2010). Similarly, prohibitins, lipid scaffolds of the inner membrane, were identified as 
proteolytic substrates of Yme1 (Potting et al., 2010). However, further endogeneous 
substrates of Yme1 remain to be identified.  
Mgr1 and Mgr3, two integral inner membrane proteins, form a supercomplex of 
approximately 1000 kDa with Yme1. The deletion of either protein is not lethal and even 
the double deletion strain is viable. However, the proteolytic activity of Yme1 seems to 
be impaired in the deletion strains, suggesting an adaptor-like function of Mgr1 and Mgr3 
(Dunn et al., 2006; Dunn et al., 2008) 
Recently, a role of Yme1 in import into the mitochondrial intermembrane space was 
postulated. The import of ectopically expressed human polynucleotide phosphorylase into 
the intermembrane space of isolated yeast mitochondria was dependent on Yme1. In the 
absence of Yme1, non-imported polynucleotide phosphorylase accumulated in the cytosol 
(Rainey et al., 2006). Upon import, the polynucleotide phosphorylase remained stable in 
the intermembrane space and was not degraded by Yme1. This observation suggets that 
Yme1 may have a function apart from its proteolytic activity 
As mentioned before, already thirteen years ago, in vitro experiments raised the idea 
of a chaperone-like function of Yme1. The recombinantly expressed and purified AAA 
domain of Yme1 was shown to mediate refolding of two model substrates, rhodanese and 
DHFR (Leonhard et al., 1999). In vivo experiments proving this hypothesis are, however, 
missing so far.  
	   	   INTRODUCTION	  
 
	   30	  
1.7 Aim of the present study  
 
The aim of this study was to gain insight into the folding of proteins in the 
mitochondrial intermembrane space. For this purpose, mouse dihydrofolate reductase, a 
protein that is frequently used to analyze translocation into mitochondria and subsequent 
folding processes, was to be expressed in the intermembrane space of mitochondria in 
intact yeast cells. The folding of dihydrofolate reductase was to be investigated under 
different conditions. Furthermore, its folding helpers would be determined and, finally, 
endogenous substrates of these folding helpers would be identified and analyzed. 
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2. MATERIALS AND METHODS 
 
2.1 Molecular biology methods 
 
2.1.1 Strategies for isolation of DNA 
 
2.1.1.1 Isolation of genomic DNA from S. cerevisiae 
For isolation of genomic DNA, an overnight culture of the respective yeast strain 
was incubated at 30 °C while shaking (130 rpm) (Rose et al, 1990). Cells were pelleted 
by centrifugation (2500 x g, 5 min, RT), washed with 20 ml H2O and disrupted by 
resuspension in 1ml breaking buffer (100 µg/ml zymolyase 20T, 1M sorbitol, 100 mM 
EDTA). After incubation for 1 h at 37 °C, the cells were washed with 1ml 1 M sorbitol 
and 100 mM EDTA, pelleted by centrifugation, resuspended and then incubated in 1 ml 
lysis buffer (50 mM Tris/HCl, 20 mM EDTA, 1 % (w/v) SDS, pH 7.5) for 30 min at 65 
°C. The cell solution was supplemented with 400 µl 5 M potassium acetate and incubated 
for 1 h on ice. DNA was separated from the protein fraction by centrifugation (20000 x g, 
15 min, 4 °C). The supernantant was transferred to a new tube, DNA precipitated with 
isopropanol and pelleted by centrifugation (37000 x g, 10 min, 2 °C). After washing with 
70 % ethanol, the DNA pellet was dried for 10 min at RT and resuspended in 100 µl 
sterile H2O. After determination of concentration with a Nanodrop 2000c 
spectrophotometer (Promega), the DNA was stored at -20 °C. 
 
2.1.1.2 Isolation of plasmid DNA from E. coli 
Plasmid DNA was isolated in small scale or large scale from E. coli based on the 
principle of alkaline lysis (Birnboim and Doly, 1979) using the “PureYield” Plasmid 
Midiprep System (Promega). E. coli clones containing the appropriate plasmid were 
inoculated in 50 ml LBAmp medium and grown overnight at 37 °C with shaking (130 rpm, 
Infor cell shakers). Bacteria were harvested by centrifugation for 5 min at 5000 rpm in 
JA-20 rotor (Beckman centrifuge) and resuspended in 6 ml “Cell Resuspension Solution“ 
(10 mM EDTA (pH 8), 50 mM Tris/HCl (pH 7.5), 100 µg/ml RNase A). 6 ml “Cell Lysis 
Solution“ (0.2 M NaOH, 1 % (w/v) SDS) and in a second step 10 ml “Neutralization 
Solution“ (4.09 M guanidine hydrochloride (pH 4.2), 759 mM potassium acetate, 2.12 M 
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glacial acetic acid) were added. The samples were mixed gently after each step and 
centrifuged for 10 min at 10000 rpm (JA-20 rotor). The supernatant of the centrifugation 
step was loaded onto a “clearing column” on top of a “binding column” and passed 
through the column by vacuum. The “clearing column” was removed and the “binding 
column” was washed with 5 ml “Endotoxin Removal Wash“ followed by 20 ml “Column 
Wash Solution“ (8.3 mM Tris/HCl (pH 7.5), 0.04 mM EDTA (pH 8), 60 mM potassium 
acetate, 60 % ethanol). After the liquid was passed through completely, the vacuum was 
continued for 30 s to dry the membrane. DNA was eluted from the column with 600 µl 
ddH2O, concentration was determined with a Nanodrop 2000c spectrophotometer and 
DNA was stored at -20 °C. 
 
2.1.1.3 Amplification of DNA by polymerase chain reaction 
Specific DNA fragments were amplified in a thermo cycler (eppendorf) by 
polymerase chain reaction (PCR) (Saiki et al., 1985; Saiki et al., 1988). One reaction 
cycle includes the following steps: denaturation of template strands, annealing of single 
strand oligonucleotides (primers; obtained from Metabion, Martinsried/ Germany), 
elongation of primers by thermo stable DNA-polymerase. A typical 50 µl reaction mix 
contained 5 µl supplied 10x PCR buffer, 4 µl dNTP mix (dATP/ dCTP/ dGTP/ dTTP; 10 
mM), 6.25 µl 20 µM forward and reverse primer, ca. 100 ng gDNA or 10 ng plasmid 
DNA as template and 1 U Taq polymerase. When the PCR product was to be used for 
subsequent cloning, the proof-reading polymerase Pfu was used instead. For further 
analysis, PCR products were separated by agarose gel electrophoresis and isolated by gel 
extraction (see 2.1.3.1, 2.1.3.2). For diagnostic PCR of clones, 1 µl of single E. coli 
colonies resuspended in 15 µl sterile H2O were used as template. 
 
PCR cycler protocol 
Step Cycles Temperature, Time 
Initial denaturation 1 95 °C, 3 min 
Denaturation 30 95 °C, 30 s 
Annealing of primers 30 ca. 55 °C, 30 s 
Elongation of primers 30 72 °C, 1 min per 1kb 
Final elongation 1 72 °C, 10 min 
Cooling 1 4 °C, for ever 
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2.1.2 Enzymatic editing of DNA 
 
2.1.2.1 Restriction digestion of DNA 
Sequence-specific digestion of DNA was achieved by using highly specific 
restriction endonucleases in the supplied buffer (New Englang Biolabs). 2 - 5 U of 
enzyme were applied per 1 µg DNA. For an analytical approach, DNA samples were 
digested for 30 min in 10 µl reaction volume. For a preparative approach, DNA samples 
were digested for 2.5 h in 50 µl reaction volume. Incubation temperature was always 37 
°C. Digested DNA fragments were purified by agarose gel electrophoresis and 
subsequent gel extraction (see 2.1.3.1, 2.1.3.2). 
 
2.1.2.2 Ligation of DNA fragments 
The concentrations of digested vector and insert were estimated on an agarose gel. 
Linearized vector (100 - 200 ng) and 5 - 10 molar excess of DNA insert were mixed in a 
20 µl reaction containing 2 µl T4 DNA ligase and corresponding 10x T4 ligation buffer 
(50 mM Tris/HCl, 10 mM MgCl2, 1 mM DTT, 1 mM ATP, 5 % (w/v) PEG-8000, pH 7.6) 
(both New England Biolabs). Ligation reactions were incubated for 3 h at room 
temperature or at 16 °C overnight. 0.5 - 1 µl of ligation reaction were transformed into 
electro-competent E. coli cells (see 2.1.4.4). 
 
2.1.3 DNA purification and analysis 
 
2.1.3.1 Agarose gel electrophoresis 
For separation according to size, DNA samples were subjected to horizontal agarose 
gels electrophoresis. 0.8 % (w/v) agarose gels, supplemented with 0.5 g/ml ethidium 
bromide, were run in TAE buffer (40 mM Tris/ acetate, pH 7.4, 20 mM natrium acetate, 1 
mM EDTA), and DNA samples were mixed with 5x concentrated loading dye (50 % 
(w/v) glycerol, 0.25 % (w/v) bromphenol blue, 0.25 % (w/v) xylencyanol). The gels were 
run at 10-15 V/cm and DNA fragments were visualized by UV light. 
 
2.1.3.2 Extraction of DNA from agarose gels 
A piece of agarose gel containing the DNA fragment of interest was cut out with a 
scalpel under UV light (366 nm) and put into 1.5 ml reaction tube. DNA was isolated 
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from the gel using the Promega gel extraction kit through silica columns according to the 
manufacturer’s instructions. 
 
2.1.4 E. coli strains 
 
2.1.4.1 Overview of E. coli strains 
Strain Genotype Reference 
MH1 K12 derivative, melBLid, ΔnhaA1, kan+, ΔnhaB1, 
cam+, ΔlacZY, thr1, MH1 
Harel-Bronstein et al., 
1995 
BL21 
(DE3) 
B F– dcm ompT hsdS(rB– mB–) gal Studier and Moffatt, 
1986 
XL1-Blue supE44, hsdR17, recA1, endA1, gyrA96, thi-1, 
relA1, lac-, F’[proAB+, lacIq lacZ∆M15, 
Tn10(tetr)] 
Stratagene 
 
For cloning, I used the E. coli strain MH1, which is a derivative of MC1061 strain and 
harbors streptomycin resistance. For recombinant protein expression, E. coli strains BL21 
(DE3) or XL1-blue were used. The BL21 (DE3) strain has a chromosomal copy of T7 
RNA polymerase controlled by lacUV5 promoter. The strain lacks the proteases Lon and 
OmpT that stabilizes the overexpressed proteins. XL1-blue cells express the lac repressor. 
Addition of IPTG leads to its inactivation and thus to the induction of downstream 
proteins. 
 
2.1.4.2 Cultivation of E. coli  
E. coli cultures were grown in LB medium in the presence of a suitable antibiotic at 
37 °C and 130 rpm (Infor shakers). Pre-cultures were inoculated from a culture plate or 
directly from the corresponding glycerol stock. For preparation of stocks, E.coli cell 
suspension was mixed 1:1 with 87 % glycerol, snap-frozen in liquid nitrogen and stored 
at -80 °C. 
 
LB (Luria-Bertani)/ LBAmp/ LBKan 10 g/l bacto-trypton, 5 g/l bacto-yeast extract, 5 
g/l NaCl; optional: 100 µg/ml ampicillin/ 
kanamycin 
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For preparation of the according agar plates, 2 % (w/v) agar was added before 
autoclaving and plates were poured when the medium was cooled down to ca. 60 °C. 
 
2.1.4.4 Preparation of electro-competent E. coli cells 
1 ml of 50 ml overnight E. coli culture was inoculated into 500 ml LB medium and 
incubated at 37°C in a shaker until an OD600 of ca. 0.5 was reached. The culture was 
incubated on ice for 30 min followed by sedimentation through centrifugation for 5 min 
at 5000 rpm (JA-10 rotor, Beckman Coulter) at 4 °C. The cell pellet was washed with 
500, 250 and 50 ml of ice-cold, 10 % (v/v) glycerol solution. The pellet was resuspended 
in 500 µl 10 % glycerol, and 40 µl aliquots were stored at -80 °C. 
 
2.1.4.5 Transformation of E. coli with plasmid DNA by electroporation 
One µl of ligation reaction or of 1:100 diluted plasmid DNA was added to a 40 µl 
solution of electro-competent cells (see 2.1.4.4). The mixture was transferred to an ice-
cold 2 mm electroporation cuvette, put into “GenePulser” (Bio-Rad) electroporator and 
transformed by a singular short voltage pulse at 2.5 kV/ 400 Ω/ 25 µF. Afterwards, the 
cells were immediately diluted in 1 ml pre-warmed LM medium, transferred to a 1.5 ml 
reaction tube and incubated for 30 min at 30 °C shaking at 130 rpm. Cells were pelleted, 
resuspended in 100 µl of residual supernatant and plated on LB plates supplemented with 
the required antibiotics. The plates were incubated over night at 37 °C and ca. 15 single 
colonies analyzed by diagnostic PCR. 
 
2.1.5 Plasmids and cloning strategies 
 
2.1.5.1 Overview of plasmids used for expression in E. coli 
 
 
 
 
Plasmid Reference 
pET28a+-Yme1_AAA-His6 This thesis 
pMAL-cRI-Imp1 This thesis 
	   	   MATERIALS	  AND	  METHODS	  
 
	   36	  
2.1.5.2 Cloning strategies 
 
a) Cloning of Yme1_AAA-His6 into pET28a+  
The coding sequence for amino acid residues 250 - 525 of Yme1 was amplified from 
genomic DNA by PCR using Yme1_AAA_for and Yme1_AAA_rev primers and cloned 
into the pET28a+ bacterial expression vector (Novagen) upstream of the plasmid-encoded 
His6-tag using NcoI and XhoI restriction sites. 
 
Yme1_AAA_for 5’-CC CCC ATG GGG GGT TTT AAA TAC ATC ACA G-3’ 
Yme1_AAA_rev 5’-CCC CTC GAG CTT TCT CTC AGC ACC C-3’ 
 
b) Cloning of Imp1 into pMAL-cRI  
The coding sequence of Imp1 was amplified from genomic DNA by PCR using 
Imp1_Mal_for and Imp1_Mal_rev primers and cloned into the pMAL-cRI bacterial 
expression vector (NEB) downstream of the plasmid-encoded MBP-tag using PstI and 
HindIII restriction sites. 
 
Imp1_Mal_for 5’-CCC CTG CAG ACT GAG ACG AGG GGA GAA TC-3’ 
Imp1_Mal_rev 5’-CCC CCC AAG CTT TCA GTT GCT CTT AGC CTG CAC 
ATC TAG-3’ 
 
2.1.5.3 Overview of plasmids used for transformation into S. cerevisiae 
Yeast strain Reference 
pYES2-Cyb2(1-107)DHFRWT   
(= IMS-DHFRWT) 
Popov-Celeketic et al., 2011 
pYES2-Cyb2(1-107; ∆19 )DHFRWT                             
(= matrix-DHFRWT) 
This thesis 
pYES2-Cyb2(1-107)DHFRmut(7/42/49)                             
(= IMS-DHFRmut) 
This thesis 
pYES2-Cyb2(1-107; ∆19)DHFRmut(7/42/49)                           
(= matrix-DHFRmut) 
This thesis 
pYES2-Cyb2(1-107)DHFRWTHis9                        
 (= IMS-DHFRWTHis) 
Popov-Celecétic et al., 2011 
pYES2-Cyb2(1-107; ∆19)DHFRWTHis9                             This thesis 
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(= matrix-DHFRWTHis) 
pRS314-Yme1 This thesis 
pRS314-His9-Yme1 This thesis 
 
2.1.5.4 Cloning strategies 
 
a) Cloning of Cyb2(1-107)-DHFRmut(-His9) and Cyb2(1-107; ∆19)-DHFRmut(-His9)   
    into pYES2 
The coding sequence of DHFRmut (Mus musculus) containing point mutations at 
position 7 (cysteine to serine), 42 (serine to cysteine) and 49 (asparagine to cysteine) was 
amplified by PCR from the plasmid pGEM4Su9-DHFRmut using forward primer 
BamDHFRC7S_for and HindDHFR_rev or HindDHFR_His9 reverse primers, 
respectively. DHFRWT inserts were excised from plasmids pYES2-Cyb2(1-107)DHFRWT 
and pYES2-Cyb2(1-107; ∆19)DHFRWT by restriction digest with BamHI and EcoRI and 
replaced with the PCR-amplified inserts DHFRmut and DHFRmutHis9 using  BamHI and 
EcoRI restriction sites in the primers. 
 
BamDHFRC7S_for 5’-CCC GGA TCC ATG GTT CGA CCA TTG AAC TCC-3’ 
DHFR_Eco_rev 5’-TTT GAA TTC TTA GTC TTT CTT CTC GTA GAC 
TTC-3’ 
DHFRHis9_Eco_rev 5’-TTT GAA TTC TTA ATG GTG ATG GTG ATG GTG ATG 
GTG ATG GTC TTT CTT CTC GTA GAC TTC-3’ 
 
b) Cloning of N-terminal His-tagged Yme1 into pRS314 
The plasmid pRS314-Yme1 was amplified by PCR using Yme1_N-His_for and 
Yme1-N-His_AgeI_rev primers, which anneal after base triplet 50 of the YME1 sequence 
coding for a serine. The His9-tag was encoded by the two primers and thus introduced 
behind the presequence of Yme1. Successful cloning was determined by restriction digest 
of the amplified PCR product with AgeI, whose restriction site was introduced by the 
reverse primer. 
 
Yme1_N-His_for 5’-CAT CAC CAT CAC GAA AAG AAT AGC GGT GAA ATG 
CCT CCT AAG-3’ 
Yme1-N-
His_AgeI_rev 
5’-GTG ATG GTG ATG GTG AGA ATA AAA CCG GTA GAA 
CTT CTT TGA TC-3’ 
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c) Amplification of mitochondrial DNA in the Δyme1 strain 
Towards addressing the DNA content of mitochondria in Δyme1 strain, Atp8, 
encoded in the mitochondrial genome, was amplified with Atp8_for and Atp8_rev 
primers by PCR. The PCR reaction was separated on a 0.8 % agarose gel and DNA bands 
were visualized under UV-light. 
 
Atp8_for 5’-TAT ATT ACA TCA CCA TTA GAT C-3’ 
Atp8_rev 5’-AGC CCA GAC ATA TCC CTG AAT G-3’ 
 All clonings were finally confirmed by sequencing (Metabion, Martinsried). 	  
2.2 Yeast genetic methods 
 
2.2.1 Overview of S. cerevisiae strains used 
 
a) Wild-type strains 
Yeast strain Genotype Reference 
YPH499  Mat a ura3-52 lys2-801_amber ade2-
101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1 
(Sikorski and Hieter, 1989) 
W303-1A  w303 Mat α ade2-1; his3-11; leu2, 112; 
trp1; ura23-53; can1-100 
(Sherman and Wakem, 
1991) 
 
b) Strains generated by homologous recombination 
Yeast strain Reference 
YPH499∆YME1::KANMX4  This thesis 
YPH499Yme1-His6 This thesis 
YPH499∆MGR1::HIS3 This thesis 
YPH499∆MGR3::HIS3 This thesis 
YPH499Mpm1-myc This thesis 
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2.2.2 Homologous recombination in S. cerevisiae 
 
a) Deletion of YME1 gene 
YME1 was deleted by homologous recombination with the corresponding PCR 
product, amplified from pFA6KANMX4 (Wach et al., 1997) using Yme1delta_for and 
Yme1delta_rev primers in the haploid yeast strain YPH499. To select for positive clones, 
transformed yeast cells were grown on medium containing kanamycin. Homologous 
recombination was confirmed by PCR, and the absence of Yme1 by “Fast Mitoprep”. 
 
Yme1delta_for 5’-TAA TTA TAA TAC ATT GTG GAT AGA ACG AAA ACA 
GAG ACG TGA TAG CGT ACG CTG CAG GTC GAC-3’ 
Yme1delta_rev 5’-GTC TTG AGG TAG GTT CCT TCA TAC GTT TAA CTT 
CTT AGA ATA AAA ATC GAT GAA TTC GAG CTC-3’ 
 
c) Chromosmal His7-tagging of C-terminus of Yme1 
Yme1_His_for primer, consisting of the last 45 3’ bases of YME1 and 18 bases of 
pYM5 plasmid, and Yme1_His_rev primer, consisting of the 45 first bases of YME1 3’-
UTR followed by 18 further bases of pYM10 plasmid, were used to amplify a PCR 
fragment from pYM10 containing 5’ to 3’ the following sequences: the last 45 3’ bases of 
YME1, His7-coding sequence, HIS cassette and 45 bases of the beginning of the 3’-UTR. 
The PCR fragment was transformed into the YPH499 wild-type strain, and homologous 
recombination confirmed by PCR. Transformants were selected on medium lacking 
histidine. 
 
Yme1_His_for 5’-GAT ATA GGC GAT GAT AAA CCC AAA ATT CCT 
ACA ATG TTA AAT GCA CAC CAT CAC CAT CAC CAT 
CAC-3’ 
Yme1_His_rev 5’-GGT GTT ATG AAG CAA AAG CGA AAC CGA CCA 
GAA AAG AAC AAA GCA TTC ATC GAT GAA TTC GAG 
CTC G-3’ 
 
b) Deletions of MGR1 and MGR3 genes 
MGR1 and MGR3 genes were deleted by homologous recombination in the haploid 
yeast strain YPH499 with the corresponding PCR products amplified by Mgr1delta_for 
and Mgr1delta_rev or Mgr3delta_for and Mgr3delta_rev primers. PCR products 
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contained the auxotrophic HIS3 marker cassette and short sequences homologous to the 
flanking regions of MGR1 or MGR3 loci. Selection for positive clones was performed on 
medium lacking histidine. Homologous recombination was confirmed by PCR with 
Mgr1con_for and Mgr1con_rev primers or Mgr3con_for and Mgr3con_rev primers. 
 
Mgr1delta_for 5’-CAT CCT CCT CCA TTC CCT CTC CTT TTC CAA TTA 
CCG TAA TAA AAG CGT ACG CTG CAG GTC GAC-3’ 
Mgr1delta_rev 5’-AAG GAT TTA ATA TAC GCA CGG TAC AAC TAA GCA 
ATC CGC AAA GAC ATC GAT GAA TTC GAG CTC-3’  
Mgr3delta_for 5’-CAG GAA GAT CTC AGT TTA ACA GGC TAA AAG TCC 
CTC CTT TTC GGT CGT ACG CTG CAG GTC GAC-3’ 
Mgr3delta_rev 5’-TTG AAA TAT TTA TTA TTT TTG TCT TCC TTT ATT 
TCC TTT ATT GTG ATC GAT GAA TTC GAG CTC  
Mgr1con_for 5’-TTC AAA CAC AAT AGT TGT TCG -3’ 
Mgr1con_rev 5’-TCT CCA AAG GGC AAA GAA ACC-3’ 
Mgr3con_for 5’-AAC TGT TCA TTG CTT TGT TCC-3’ 
Mgr3con_rev 5’-TTT TTT CAA ATT GGG TTT AGG-3’ 
 
c) Chromosmal myc-tagging of the C-terminus of Mpm1 
Mpm1_myc_for primer, consisting of the last 45 3’ bases of MPM1 and 18 bases of 
pYM5 plasmid, and Mpm1_3’-UTR_rev primer, consisting of the 45 first bases of MPM1 
3’-UTR followed by 18 further bases of pYM5 plasmid, were used to amplify a PCR 
fragment from pYM5 containing 5’ to 3’ the following sequences: last 45 3’ bases of 
MPM1, myc-coding sequence, HIS cassette and 45 bases of the beginning of 3’-UTR. 
The PCR fragment was transformed into the YPH499 wild-type strain, and homologous 
recombination confirmed by PCR. Transformants were selected on medium lacking 
histidine. 
Mpm1_myc_for 5’-AGT CCC CAG GTG AAG CAT AAA GTG GTG AGT 
GTT GAC GAA GAC ATT CGT ACG CTG CAG GTC GAC-
3’ 
Mpm1_3’-UTR_rev 5’-CAT ATT GTG TAA GAT ATG AGT AAA AAA AGG 
AAA CGA AAA TAT GTC ATC GAT GAA TTC GAG CTC-
3’ 
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2.2.3 Strains generated by transformation with yeast expression vectors 
Yeast strain Reference 
YPH499 + pYES2-Cyb2(1-107)DHFRWT                              
                  (= IMS-DHFRWT) 
This thesis 
YPH499 + pYES2-Cyb2(1-107; ∆19 )DHFRWT                              
                  (= matrix-DHFRWT) 
This thesis 
YPH499 + pYES2-Cyb2(1-107)DHFRmut(7/42/49)                              
                  (= IMS-DHFRmut(7/42/49)) 
This thesis 
YPH499 + pYES2-Cyb2(1-107; ∆19)DHFRmut(7/42/49)                             
                  (= matrix-DHFRmut7/42/49) 
This thesis 
YPH499 + pYES2-Cyb2(1-107)DHFRWTHis                              
                  (= IMS-DHFRWTHis) 
This thesis 
YPH499 + pYES2-Cyb2(1-107; ∆19)DHFRWTHis                              
                  (= matrix-DHFRWTHis) 
This thesis 
YPH499∆YME1::KANMX4  
+ pYES2-Cyb2(1-107)DHFRWT  
    (= IMS-DHFRWT) 
This thesis 
YPH499∆YME1::KANMX4  
+ pYES2-Cyb2(1-107; ∆19)DHFRWT 
    (= matrix-DHFRWT) 
This thesis 
YPH499∆YME1::KANMX4  
+ His6-Yme1  
+ pYES2-Cyb2(1-107)DHFRWT  
    (= IMS-DHFRWT) 
This thesis 
YPH499∆YME1::KANMX4  
+ His6-Yme1  
+ pYES2-Cyb2(1-107; ∆19)DHFRWT             
     (= matrix-DHFRWT) 
This thesis 
YPH499Yme1-His6  
+ pYES2-Cyb2(1-107)DHFRWT  
    (= IMS-DHFRWT) 
This thesis 
YPH499Yme1-His6  
+ pYES2-Cyb2(1-107; ∆19)DHFRWT 
     (= matrix-DHFRWT) 
This thesis 
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YPH499∆MGR1::KANMX4  This thesis 
YPH499∆MGR3::KANMX4  This thesis 
YPH499∆MGR1::KANMX4  
+ pYES2-Cyb2(1-107)DHFRWT  
    (= IMS-DHFRWT) 
This thesis 
YPH499∆MGR3::KANMX4  
+ pYES2-Cyb2(1-107)DHFRWT  
    (= IMS-DHFRWT) 
This thesis 
YPH499∆MGR1::KANMX4  
+ pYES2-Cyb2(1-107; ∆19)DHFRWT  
    (= matrix-DHFRWT) 
This thesis 
YPH499∆MGR3::KANMX4  
+ pYES2-Cyb2(1-107; ∆19)DHFRWT  
    (= matrix-DHFRWT) 
This thesis 
 
2.2.4 Cultivation of S. cerevisiae 
Yeast strains were grown according to standard methods (Sherman, 1991). For 
stocks, yeast cells were taken from a plate with an inoculation loop, transferred into 15 % 
(v/v) glycerol, snap-frozen in liquid nitrogen and stored at -80 °C. For cultivation, yeast 
strains from the stock solution were spread on YPD or selective agar plates. Selective 
plates lacked one or more particular selection markers so that only successfully 
transformed cells containing the plasmid would grow. After incubation at 30 °C, liquid 
cultures were inoculated from these plates into 50 ml of medium and incubated at 30 °C 
at 130 rpm shaking (Infor cell shakers). The cell culture was grown in the logarithmic 
phase for 2-3 days before inoculating the large cultures. For activation of the GAL 
promoter of yeast expression plasmid pYES2, 0.5 % galactose (w/v) was added two hours 
before harvesting.  
 
2.2.5 Media for cultivation of S. cerevisiae  
Lactate medium 3 g yeast extract, 1 g KH2PO4, 1 g NH4Cl, 0.5 g CaCl2 x 2 H2O, 0.5 g 
NaCl, 1.1 g MgSO4 x 6 H2O, 0.3 ml 1 % FeCl3, 22 ml 90 % lactic 
acid, H2O ad 1 l, pH 5.5 adjusted with KOH; supplemented with 0.1 
% glucose 
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YPD medium  10 g yeast extract, 20 g bacto-peptone, H2O to 930 ml, pH 5.5 
adjusted with KOH; supplemented with 2 % glucose 
YPG medium  10 g yeast extract, 20 g bacto-peptone, H2O to 930 ml, pH 5.5 
adjusted with KOH; supplemented with 3 % glycerol 
YPGal medium 10 g yeast extract, 20 g bacto-peptone, H2O ad 930 ml, pH 5.5 
adjusted with KOH; supplemented with 2 % galactose 
SD medium 1.74 g yeast nitrogen base, 5 g (NH4)2SO4, 20 g glucose, H2O ad 1 l 
SLac medium 1.7 g yeast nitrogen base, 5 g (NH4)2SO4, 22 ml 90 % lactic acid, 
H2O ad 1 l, pH 5.5 adjusted with KOH 
SILAC medium SLac medium containing heavy Lysine (L-Lysine-13C6, 15N2 
hydrochloride) 
 
Amino acids for selective media were prepared separately. 10 mg/ml solutions of 
histidine, leucine, lysine and 2 mg/ml solutions of uracil and adenine were autoclaved for 
20 min at 120 °C. 10 mg/ml solutions of tryptophan were not autoclaved but filtered for 
sterilization. For preparation of the corresponding plates, 2 % (w/v) agar was added 
before autoclaving and plates were poured when the medium was cooled down to ca. 60 
°C. 
 
2.2.6 Lithium acetate transformation of S. cerevisiae 
A pre-culture of the appropriate yeast strain was inoculated, grown overnight and 
diluted to an OD600 of 0.1 - 0.2 in 50 ml the following morning. Cells were grown for two 
cell divisions to an OD600 of 0.5 - 0.6 and pelleted by centrifugation in sterile 50 ml tubes 
for 5 min at 3000 x g. The cell pellet was washed with sterile water, resuspended in 1 ml 
100 mM lithium acetate and transferred to an 1.5 ml reaction tube. After centrifugation 
for 15 sec at 13200 rpm (eppendorf table-top centrifuge 5415D) the cell pellet was 
resuspended in ca. 400 µl 100 mM lithium acetate to a final volume of 500 µl. 50 µl cell 
suspension per transformation was prepared in separate 1.5 ml reaction tubes and 
centrifuged for 5 min at 3000 x g. After removing the lithium acetate supernantant, 240 µl 
50% polyethylene glycol, 36 µl 1M lithium acetate, 5 µl 10 mg/ml single strand DNA, 
0.1 - 10 µg plasimd or PCR product and 60 µl H2O were added one after the other and 
then mixed thoroughly on the vortexer for 1 min. After incubation for 30 min at 30 °C 
and 200 rpm, followed by 25 min incubation at 42 °C, cells were sedimented for 15 sec at 
8000 rpm and the transformation supernatant was removed. Cells were resuspended in 
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100 µl sterile H2O streaked out on appropriate selective plates. In the case of kanamycin 
resistance, cells were incubated for 2 - 3 hours at 30 °C before plating. 
 
2.2.7 Test for growth phenotype of S. cerevisiae 
The yeast strains of interest were inoculated into 20 ml pre-culture and diluted to an 
OD600 of 0.1 - 0.2 the next morning. After growth for two cell divisions to an OD600 of 0.5 
- 0.6, 0.1 OD600 was collected, washed in sterile H2O and resuspended in 100 µl sterile 
H2O. Starting from this cell suspension, four serial 1:10 dilutions were prepared and 2 µl 
of each dilution was spotted on YPD and YPG plates. Four copies of each plate were 
prepared for incubation at 16 °C, 24 °C, 30 °C and 37 °C. Growth was monitored every 
day and pictures of the plates were taken as soon as the cells of highest dilution started 
growing.  
 
 
2.3 Protein biochemistry methods 
 
2.3.1 Analytical methods 
 
2.3.1.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated on discontinuous SDS-PAGE according to their size 
(Laemmli et al., 1970). For large gels, the running gel was 9 x 15 x 0.1 cm and the 
stacking gel 1 x 15 x 0.1 cm in size. For mini gels the Bio-Rad Mini-Protean II apparatus 
(7 x 7.2 x 0.075 cm; stacking gel: 1 x 7.2 x 0.075 cm) was used. The concentration of 
acrylamide-bisacrylamide (Serva) in the running gel was chosen appropriate to the sizes 
of to be separated proteins and was usually between 8 and 14 %.  Before pouring the gel, 
the glass plates were sealed with 2 % (w/v) Agar-Agar (Roth) in running buffer. Protein 
samples to be analyzed were dissolved in Laemmli buffer (120 mM Tris/HCl pH 6.8, 4 % 
SDS, 20 % glycerol, 0.01 % bromophenol blue with or without 5 % (v/v) β-
mercaptoethanol and boiled for 3 min at 95 °C before loading on the gel. Large gels were 
run at 35 mA (EP601 power supply/ GE Healthcare) and mini gels at 25 mA until the 
bromophenol blue front reached the bottom of the running gel.  
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2.3.1.2 Coomassie Brilliant Blue staining of SDS gels 
Proteins that were separated by electrophoresis were briefly washed in H2O before 
staining by incubation of the gel in Coomassi Brilliant Blue (40 % methanol, 10 % acetic 
acid, 0.1 % Coomassi Brilliant Blue R-250) for ca. 60 min. Consequently, the gel was 
destained by repeated incubation in 40 % methanol, 10 % acetic acid and then washed in 
water again. 
 
2.3.1.3 Drying of Coomassie-stained gels 
The CBB-stained gel was assembled between two plastic sheets of in water-soaked 
gel drying films (Promega), fixed by two rectangular plastic frames and dried over night 
in a fume hood. 
 
2.3.1.4 Transfer of proteins onto nitrocellulose membranes (western blot) 
Proteins separated by electrophoresis were transferred onto nitrocellulose according 
to semi-dry method (Khyse-Anderson, 1984). Two blotting papers (neoLab), one 
nitrocellulose membrane (Whatman) and the gel were soaked in blotting buffer (20 mM 
Tris, 150 mM glycine, 0.02 % SDS, 20 % methanol) and assembled to a sandwich in the 
following order: blotting paper, nitrocellulose membrane, gel, blotting paper. The 
sandwich was assembled between two graphite electrodes (made in-house by the 
departmental workshop) and the negatively charged proteins were transferred onto the 
nitrocellulose membrane by applying constant current (250 mA) for 1 hour. A wet blot 
sandwich consisted of blotting paper, nitrocellulose membrane and the gel was fixed 
between two grids transfer took place in a chamber filled with blotting buffer (Towbin et 
al., 1979). Transfer was performed for 1.5 hours at 400 mA and 4 °C. Transferred 
proteins on the nitrocellulose membrane were stained with Ponceau S. Immuno-staining 
of proteins on the membranes and detection of ECL signals was performed as described 
in 2.5.6. 
 
2.3.1.5 Protein precipitation by trichloracetic acid (TCA) method 
Proteins were precipitated from a solution by addition of 72 % (w/v) TCA to a final 
concentration of 12 % TCA in the sample. Samples were mixed vigorously and put at -20 
°C for 30 min prior to high speed centrifugation (20000 rpm/ 12154-H rotor/ Sigma) at 4 
°C for 20 min. After removing the TCA supernatant and washing the protein pellet with 
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ice-cold acetone, the pellet was dried for 10 min at room temperature, dissolved in 2x 
Laemmli buffer with 5 % (v/v) β-mercaptoethanol and heated at 95 °C for 5 min. 
 
2.3.1.6 Determination of protein concentration 
For determination of protein concentration, duplicates of 3 and 6 µ l of protein 
solution were supplemented with 1 ml of 1:5 diluted Bradford Reagent (Bio-Rad). After 
incubation at room temperature for 10 min, the absorbance at 595 was measured and 
protein concentration determined by a calibration curve derived from absorbances of 
protein solution of known concentrations (0; 1,5; 3; 6; 12; 24 µg/ml) of bovine IgG 
standard. 
 
2.3.1.7 Autoradiography 
For visualization of radioactively labeled proteins on nitrocellulose membrane, the 
membranes were dried under red light and exposed to X-ray films (Kodak Bio Max MM). 
After an appropriate time of exposure, protected from light by special Kodak film 
cassettes, the films were developed in a Gevamatic 60 developing machine (AGFA-
Gevart). The exposure time was adapted to the signal intensities, and ranged from one 
day to several weeks.  
 
2.3.1.8 Detection and quantification of ECL and radioactive signals on films 
Signals on sensitive films were detected and scanned with an ImageScanner (GE 
Healthcare) and quantified using the accompanying Master 1D Elite software (GE 
Healthcare). 
 
 
2.3.2 Preparation of proteins 
 
2.3.2.1 Overexpression of recombinantly expressed Yme1-AAA-His6 and MBP-Imp1 
The AAA domain (amino acid residues 250 - 525) of S. cerevisiae Yme1 coupled to 
C-terminal His6-tag was expressed in the BL21 (DE3) E. coli strain from the pET28a+ 
expression vector (Novagen). Similarly, N-terminally MBP-tagged Imp1 was as well 
expressed in the BL21 (DE3) E. coli strain from the pMAL-cRI vector (New England 
Biolabs). Overnight cultures of transformed BL21 (DE3) were used to inoculate 4 l main 
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cultures and grown further at 37 °C to an OD600 0.8. Expression of the recombinant 
protein was induced by addition of IPTG to a final concentration of 0.5 mM and grown 
for an additional 2.5 h at 37 °C. 1 ml samples of cell culture before induction and after 2.5 
h induction were taken out, spun down and resuspended in 100 µl 2x Laemmli with 5 % 
(v/v) β-mercaptoethanol per 1 OD600. Samples were loaded on mini gels and stained with 
Coomassie to monitor the induction of protein expression. The residual cell culture was 
harvested by centrifugation at 5000 rpm (JA-10 rotor, Beckman centrifuge) and 4 °C for 5 
min, washed with H2O and transferred to 50 ml reaction tubes. Cells were pelleted by a 
further centrifugation step for 10 min at 4 °C and 4000 rpm (SX4250 rotor/ Beckman X-
22R Benchtop Falcon Centrifuge) and either immediately processed further or stored at -
20 °C. 
 
2.3.2.2 Purification of recombinantly expressed His-tagged AAA domain of Yme1 
The pellet of E. coli cells overexpressing S. cerevisiae Yme1 AAA-His6 was 
resuspended in buffer (150 mM KCl, 50 mM Tris, 15 mM imidazol, pH 8, 1 mM PMSF). 
Lysozyme was added to 1 mg/ml final concentration and the suspension was incubated at 
4 °C for 30 min. Cells were disrupted by sonication (Branson Sonifyer 250) with 12 x 12 
sec pulses (duty cycle 80 %, setting 4) on ice and 18 sec breaks on ice in between. Cell 
suspension was transferred to JA20 centrifugation tubes and unopened cells were pelleted 
by centrifugation at 15000 rpm (JA 20 rotor, Beckmann) and 4 °C for 15 min. The 
supernatant was loaded onto 2 ml Ni-NTA column. After washing with three column 
volumes of buffer (150 mM KCl, 50 mM Tris, 15 mM imidazol, pH 8, 1 mM PMSF), the 
His-tagged protein was eluted with 250 mM imidazol in the same buffer and collected in 
15 separate 1 ml fractions. The protein content of each fraction was tested by Ponceau S 
staining of 2 µ l drops of the fractions on a nitrocellulose membrane. The exact protein 
concentration in the peak elution fractions 4 - 7 was determined by Bradford assay. 
Samples of 30 µg of recombinant protein per lane were loaded onto 14 % SDS gels. After 
electrophoresis, proteins were transferred onto nitrocellulose membrane by western blot 
and visualized by Ponceau S staining. Protein bands containing the overexpressed His-
tagged AAA domain of Yme1 were cut out, destained and dissolved in DMSO prior to 
injection into rabbit once per month (see 2.5.3). 
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2.3.2.3 Coupling of peptides to SulfoLink beads  
The peptide that was used for injection into the rabbit for antibody production was 
also used for affinity purification of the specific antibodies according to ThermoScientific 
protocol. For this purpose, 2 ml of SulfoLink Resin were transferred with a wide-bore 
pipette to an empty column, resulting in a final volume of 1 ml of settled beads. The 
column was equilibrated with 4 column volumes of coupling buffer (50 mM Tris, 5 mM 
EDTA-Na, pH 8.5). The lyophilized peptide was dissolved in coupling buffer (2 ml) and 
added to the column. The peptide was given time for binding to the SulfoLink resin by 
over-end-mixing at room temperature for 15 min and incubation at room temperature 
without mixing for a further 30 min. The column was then washed with 3 column 
volumes coupling buffer and the non-specific binding sites were blocked by mixing with 
one bed-resin 50 mM L-Cysteine-HCl in coupling buffer for 15 min and further 
incubation for 30 min, both at room temperature. The column was washed with six 
column volumes 1 M NaCl and two column volumes of storage buffer (0.1 M Tris, 0.5 M 
NaCl, pH 8) before being stored in storage buffer with 0.05 % natrium azide at 4 °C. 
 
2.3.2.4 Purification of antibodies 
For purification of specific antibodies from the serum, the prepared SulfoLink 
column was equilibrated to room temperature and in case the column was used for the 
first time, it was washed with 10 ml 0.1 M glycine, pH 2.5 and 10 ml 0.1 M Tris, pH 8.8. 
After equilibration with 10 ml 10 mM Tris, pH 7.5, 6 ml of serum diluted with 24 ml 10 
mM Tris, pH 7.5, 1 mM PMSF were loaded onto the column. The column was washed 
with 10 ml 10 mM Tris, pH 7.5 and 10 ml 10 mM Tris, pH 7.5, 0,5 M NaCl before 
elution in three steps was performed. First, antibodies were eluted with 10 ml 0.1 M 
citrate pH 4.0 and collected in 1 ml fractions that were equilibrated with 200 µl 1 M Tris, 
pH 8.8. Collected 1 ml fractions of the second elution step with 10 ml 0.1 M glycine, pH 
2.5 were equilibrated with 150 µl 1 M Tris, pH 8.8 and the collected 1 ml fractions of the 
third elution step with 10 ml 0.1 M natrium phosphate, pH 11 were equilibrated in 150 µl 
1 M glycine, pH 2.2. Nitrocellulose membranes with 25 µg of alternately loaded wild-
type and Δyme1 mitochondria were immuno-stained with samples of all elution fraction 
diluted 1:250 in milk. Usually, most proteins were eluted with glycine and acidic pH. 
After use, SulfoLink columns were washed with 10 ml 0.1 M Tris pH 8.8 and stored in 
storage buffer with 0.05 % natrium azide for further purifications. 
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2.4 Cell biology methods 
 
2.4.1 NaOH cell disruption (Kushnirov, 2000) 
50 ml pre-culture was grown over night, diluted to an OD600 0.2 in the morning and 
grown for 2 cell divisions until an OD600 of 0.6. 2 OD600 of culture were harvested by 
centrifugation at 14000 rpm (table top Eppendorf centrifuge) and room temperature for 5 
min. The cell pellet was resuspended in 200 µl 0.1 M NaOH and incubated for 5 min at 
room temperature. Disrupted cells were pelleted by centrifugation at 14000 rpm (12154-
H rotor/ Sigma) at room temperature for 5 min, resuspended in 50 µl 2x Laemmli with 5 
% (v/v) β-mercaptoethanol per 1 OD600 and 0.5 - 1 OD600 were loaded per lane onto 
appropriate SDS-PA gels. 
 
2.4.2 “Rödel’s” cell disruption (Horvath and Riezman, 1994) 
A second method for disruption of yeast cell is ‘Rödel’s’ cell lysis. Yeast cells were 
grown and harvested as described for NaOH lysis. The cell pellet was resuspended in 50 
µl ‘Rödel’s’ mix (1.85 M NaOH, 7.4 % β-mercaptoethanol, 20 mM PMSF), vigorously 
mixed on the vortexer (VF2/ Janke und Kunkel) and incubated for 15 min on ice. Proteins 
were precipitated with TCA as described under 2.3.1.5 and analysed by SDS-PAGE, 
western blot and immuno-staining. 
 
2.4.3 “Fast Mitoprep” 
Yeast strains were grown overnight, diluted in the morning and grown to OD600 of 
0.6 - 0.8. and 5 - 10 OD600 were collected in 15 ml reaction tubes and pelleted by 
centrifugation at 3000 rpm (SX4250 rotor/ Beckman X-22R Benchtop Falcon Centrifuge) 
for 5 minutes at room temperature. The pellet was resuspended in 300 µl of 0.6 M 
sorbitol, 20 mM Hepes, pH 7.4, 80 mM KCl, 2 mM PMSF, transferred to a 1.5 ml 
reaction tube and 200 µl cold glass beads (diameter: 0.5 mm) were added. Cells were 
lysed by four-times mixing steps with a vortexer (VF2/Janke und Kunkel) for 30 sec. 
Samples were placed on ice in between. The supernatant after centrifugation at 1000 xg 
and 4 °C for 3 min was transferred to a fresh reaction tube and spun down a second time 
for 10 min at 14000 rpm (12154-H rotor/ Sigma) and 4 °C. The supernatant of this spin 
was transferred to a new reaction tube and proteins were precipitated with the TCA 
method (see 2.3.1.5). Pellet fractions were directly resuspended in 20 µl 2x Laemmli 
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buffer with 5 % (v/v) β-mercaptoethanol. Supernatant and pellet fraction, representing 
cytosolic and crude mitochondrial fractions, respectively, were subjected to SDS-PAGE, 
transferred to nitrocellulose membrane by western blot and analyzed by immuno-staining 
with antibodies against the proteins of interest and diverse mitochondrial and cytosolic 
marker proteins as controls. 
 
2.4.4 “Big Mitoprep” (Modified after Daum et al., 1982) 
For large-scale mitochondrial isolation, yeast cells were grown for 2 - 3 days before 
inoculation of the main culture (2 - 8 l) to an OD600 of ca. 0.1 in the evening. The cells 
were constantly kept in the logarithmic phase and diluted when necessary. In case 
proteins were to be expressed from yeast expression plasmid pYES2, 0.5 % galactose was 
added 2 hours before Mitoprep at OD600 of 0.6 for induction of the GAL promoter of the 
plasmid.  At OD600 of 0.6 - 0.8, the culture was collected in 1 l centrifugation beakers and 
spun down for 5 min at 4000 rpm (JLA-81000 rotor) and room temperature. The cell 
pellet was resuspended in H2O and transferred to JA-10 beakers. After centrifugation (5 
min, 4000 rpm/ JA-10 rotor, RT) and removal of supernatant, the wet weight of the cell 
pellet was measured. The cell pellet was resuspended in 2 ml buffer 1 (100 mM Tris, 10 
mM DTT) per 1 g wet weight and incubated at 30 °C with shaking for for ten minutes. 
Subsequently, the cells were spun down (5 min, 4000 rpm, JA-10 rotor, RT) and the 
pellet was resuspended in 50 - 100 ml 1.2 M sorbitol. After centrifugation the cell pellet 
was resuspended in 6.6 ml buffer 2 (1.2 M sorbitol, 20 mM KH2PO4, pH 7) including 6 g 
Zymolyase 20T per 1 g wet weight and incubated at 30 °C in the shaker for 45 min.  
Spheroplasts were harvested by centrifugation (5 min, 2500 rpm/ JA-10 rotor, 2 °C) 
and the pellet was resuspended thoroughly in 12.6 ml homogenization buffer (0.6 M 
sorbitol, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM PMSF, 0.2 % BSA/ fatty acid-free) 
per 1 g wet weight. The suspension was transferred to a pre-cooled glass homogenizer 
(Kontes, New Jersey), 12x homogenized on ice and transferred to JA-10 tubes. Unopened 
cells were pelleted by centrifugation (5 min, 3300 rpm/ JA-10 rotor, 2 °C) and the 
supernatant of this centrifugation was again centrifuged. The supernatant was transferred 
to JA-10 tubes and centrifuged for 12 min at 10000 rpm (JA-10 rotor) and 2 °C. The 
supernatant was discarded and the mitochondrial pellet was resuspended in 30 ml SH 
buffer (0.6 M sorbitol, 20 mM Hepes, pH 7.4) and transferred to pre-cooled JA-20 tubes. 
After centrifugation (5 min, 4000 rpm/ JA-20 rotor, 2 °C) the supernatant was transferred 
to fresh JA20 beakers and again centrifuged at 4000 rpm (2 °C) for 5 min. The 
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supernatant was then again transferred to new JA-20 tubes and mitochondria were 
pelleted by centrifugation at 12000 rpm (JA-20 rotor) and 2 °C for 12 min. The 
mitochondrial pellet was resuspended in a small amount of SH buffer adjusted to the size 
of the pellet. The protein concentration of the isolated mitochondria was determined with 
the Bradford assay (see 2.3.1.6). Mitochondria were divided into aliquots of appropriate 
amounts, snap-frozen in liquid nitrogen and stored at -80 °C. 
 
2.4.5 Generation of mitoplasts 
For disruption up the outer mitochondrial membrane, 100 µg of isolated 
mitochondria were resuspended in swelling buffer (0.2 M Hepes, pH 7.4) with 1.5 mM 
ATP and with or without 0.5 mg/ml proteinase K (PK). After incubation on ice for 20 
min, proteinase K digestion was stopped adding 1 mM PMSF, and samples were 
incubated on ice for a further 5 min. After centrifugation (14000 rpm/ 12154-H rotor/ 
Sigma, 10 min, 4 °C), pellets were resuspended in 20 µ l 2 x Laemmli buffer with 5 % 
(v/v) β-mercaptoethanol, heated at 95 °C for 5 min, subjected to SDS-PAGE and western 
blot and analyzed by immuno-staining with antibodies against the protein of interest and 
marker proteins for the outer membrane, intermembrane space, inner membrane and 
matrix. 
 
2.4.6 Digitonin fractionation of mitochondria 
Isolated mitochondria were diluted in SH (0.6 M sorbitol, 20 mM Hepes, pH 7.4) to 
a final concentration of 1 µg/µl and increasing amounts of 10 % digitonin solution were 
added to the following final concentrations: 0, 0.005, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 
0.08 and 0.1 %. In addition, proteinase K was added to the samples (50 µg/ml final 
concentration). One additional sample was kept in SH without digitonin and proteinase K 
as a control. Samples were kept on ice for 25 minutes, 200 µM PMSF was added to stop 
the proteinase K reaction and samples were incubated on ice for a further 5 minutes. After 
centrifugation for 10 min at 14000 rpm (12154-H rotor/ Sigma) and 4 °C, the pellet was 
resuspended in 2x Laemmli buffer with 5 % (v/v) β-mercaptoethanol, heated to 95 °C for 
5 min and subjected to SDS-PAGE. Western blot nitrocellulose membranes were 
immuno-stained with antibodies against the protein of interest and different mitochondrial 
marker proteins of the outer membrane, intermembrane space, inner membrane and 
matrix. 
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2.4.7 Protease treatment 
To investigate the folding states of DHFR constructs in vivo, isolated mitochondria 
were solubilized with 1 % Triton X-100 in the presence or absence of 20 µg/ml 
proteinase K. After incubation for 15 min on ice, 2 mM PMSF was added to stop the 
proteinase K reaction. After centrifugation at 14000 rpm (12154-H rotor/ Sigma) and 4 
°C for 10 min, the pellet was dissolved in 2 x Laemmli buffer containing 5 % (v/v) β-
mercaptoethanol, heated to 95 °C for 5 min and subjected to SDS-PAGE, western blot 
and immuno-staining for analysis. One set of samples was treated with the dihydrofolate 
substrate homolog methotrexate (200 µM final concentration) for 10 min prior to addition 
of Triton X-100 and PK. Samples were then analyzed by SDS-PAGE, western blot and 
immuno-staining. 
 
2.4.8 Aggregation assay 
In order to assess the aggregation of proteins expressed in vivo, isolated 
mitochondria were solubilized with 0.5 % Triton X-100, soluble and aggregate fractions 
were separated by centrifugation at 14000 (12154-H rotor/ Sigma) and 4 °C for 10 min 
and subsequently analyzed by SDS-PAGE, western blot and immuno-staining. Where 
indicated, isolated mitochondria were pre-incubated for 10 min at 25 °C, either in the 
presence of 1.5 mM ATP and 1.5 mM NADH to increase the mitochondrial ATP levels, 
or with 0.1 U/ml apyrase and 8 µM oligomycin to deplete ATP. Subsequently, 
mitochondria were incubated for 3 min at 25 °C or 42 °C prior to solubilization. Samples 
were then analyzed by SDS-PAGE, western blot and immuno-staining. 
 
2.4.9 Ni-NTA agarose pulldown 
Isolated mitochondria were incubated for 10 min at 25°C in the presence of 1 mM 
ADP or ATP or were depleted of nucleotides by addition of 0.1 U/ml apyrase, and 8 µM 
oligomycin. Subsequently, mitochondria were solubilized for 20 min at 4 °C with 1 % 
(w/v) digitonin in 20 mM Tris, pH 8.0, 80 mM KCl, 10 % glycerol, 20 mM imidazole, 1 
mM PMSF. After centrifugation at 14000 rpm (12154-H rotor/ Sigma) and 4 °C for 10 
min, solubilized material was mixed with Ni-NTA agarose beads (Qiagen) and incubated 
on an overhead roller for 60 min at 4°C. After three washing steps, proteins that were 
stably and specifically bound to the beads were eluted with Laemmli buffer containing 5 
% (v/v) β-mercaptoethanol and 500 mM imidazole. Samples were analyzed by SDS-
PAGE, western blot and immuno-staining. 
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2.5 Immunological methods 
 
2.5.1 Overview of antibodies prepared during this thesis 
Antibody Antigen Rabbit number 
α-Cyc1 full length Cyc1 (Sigma-Aldrich; # 
C2436) 
442 (animal facility, 
Pettenkoferstraße) 
α-Imp1 MBP-Imp1 (full length) 470 (animal facility, 
Pettenkoferstraße) 
α-Yme1 Yme1_AAA(250 - 525)-His6 474 (animal facility, 
Pettenkoferstraße) 
α-Yme1 C-terminal peptide 
(CDERKDIGDDKPKIPTMLNA) 
Tiere 1, 2, 3 (Pineda, Berlin) 
 
2.5.2 Further antibodies used in this study 
Antibody Description 
α-Aac2 C-terminal peptide with His6-tag, S. cerevisiae, Endres M. 
α-Ccp1 S. cerevisiae, Langer T. 
α-Cox2 C-terminal peptide, S. cerevisiae, Hell K. 
α-Cyb2 Cyb2(168 - 557)-His6, S. cerevisiae, Hell K. 
α-DHFR monoclonal, M. musculus, Origene 
α-Dld1 C-terminal peptide, S. cerevisiae, Rojo E. 
α-Erv1 Erv1-GST, S. cerevisiae, Herrmann H. 
α-Fcj1 C-terminal peptide, S. cerevisiae, Rabl R. 
α-Gut2 Gut2-His6, S. cerevisiae, Harner M. 
α-Hep1 Hep1(full length)-His6, S. cerevisiae, Sichting M. 
α-His monoclonal, Qiagen 
α-Hsp60 raised against E. coli GroEL, kind gift of Prof. Ulrich Hartl/ 
MPI, Martinsried 
α-Mcs10 MBP-Mcs10-Afl, S. cerevisiae, Mokranjac D. 
α-Mcs12/ -Aim5 MBP-Mcs12 (14 - 116), S. cerevisiae, Harner M. 
α-Mcs19/ -Aim13 C-terminal peptide (EKSPSPQAKKTAIDK), S. cerevisiae, 
Harner M. 
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α-Mcs27/ -Aim37 C-terminal peptide (AKKCDLKRQIDQTLQ), S. cerevisiae, 
Harner M.,  
α-Mge1 full length, S. cerevisiae, Sichting M. 
α-Oxa1 N-terminal peptide, S. cerevisiae, Preuß M. 
α-myc monoclonal,  H. sapiens, Sigma-Aldrich 
α-Phb2 S. cerevisiae, Rabl R. 
α-Ssc1 C-terminal peptide, S. cerevisiae, Baumann F. 
α-Tim13 Tim13-MBP, S. cerevisiae, Terziyska N. 
α-Tim14 GST-Tim14 (1 - 65), S. cerevisiae, Mokranjac D. 
α-Tim17 C-terminal peptide, S. cerevisiae, Mokranjac D. 
α-Tim21 His6-Tim21 (97 - 239), S. cerevisiae, Mokranjac D. 
α-Tim23 MBP-Tim23 (1 - 98), S. cerevisiae, Mokranjac D. 
α-Tim44 Tim44 (43 - 431)-His6, S. cerevisiae, Mokranjac D. 
α-Tim50 CTim50-IMS domain, S. cerevisiae, Mokranjac D 
α-Tom22 N-terminal peptide, S. cerevisiae, Harner M. 
α-Tom40 C-terminal peptide, S. cerevisiae 
α-Tom70 N-terminal peptide, S. cerevisiae, Käser M. 
 
2.5.3 Generation of specific antisera in rabbits 
Polyclonal antisera were generated in rabbits. Purified recombinant proteins 
expressed in E. coli were loaded onto SDS-PAGE and transferred to nitrocellulose 
membrane by western blot. The nitrocellulose membrane was stained with Ponceau S and 
the bands containing the protein of interest were cut out, destained and solubilized in 
DMSO by vortexing prior to subcutaneous injection into rabbit. For the first injection, 
200 µg protein in a volume of 250 µl were mixed 1:1 with TiterMax reagent (Sigma-
Aldrich) for 1 min on the vortexer. The emulsion was subcutaneously injected into the 
neck area of the rabbit in three steps. Further injections were performed monthly whereby 
the 200 µg protein in a 250 µl volume were mixed 1:1 with Freund’s Adjuvans 
incomplete (Sigma-Aldrich). Ca. 10 days after each injection (except the first), 10 - 30 ml 
blood were taken from the vein of the ear. After coagulation during incubation at RT for 
60 min, the blood sample was centrifuged twice (1st: 3000 x g, 5 min, RT; 2nd: 20000 x 
g, 15 min, RT) to separate the serum containing antibodies from the blood clot. The 
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serum (supernatant) was transferred to a scintillation vial, incubated at 56 °C for 20 min 
for inactivation of the complement system and stored at -20 °C. 
 
2.5.4 Detection of proteins on nitrocellulose membranes by immuno-staining 
Upon transfer of the proteins onto nitrocellulose, unspecific binding sites were 
blocked by incubation of the membrane in milk blocking solution (5 % (w/v) milk 
powder (Spinnrad) in 1x TBS (150 mM NaCl, 10 mM Tris/HCl pH 7.5) or in 3 % (w/v) 
BSA for 30 min at RT on the shaker. Subsequently, the membrane was incubated in a 
solution of antiserum or purified antibody in blocking solution. Dilutions were chosen 
according to the strength of the antibody (1:200 - 1:500) or the antiserum (1:200 and 
1:20000). After incubation for 2 h at RT or over night at 4 °C on the shaker, the 
membrane was washed in three 5 min steps on the shaker: 1x TBS, 1x TBS with 0.05 % 
TritonX-100, 1x TBS. Subsequently, the membrane was incubated in the appropriate 
dilution of monoclonal goat anti-rabbit (1:10000) or goat anti-mouse (1:5000) antibodies 
coupled to horseradish peroxidase (both Bio-Rad) in blocking solution. After shaking at 
RT for 1 h, the membrane was washed in three steps of 5 min as described before and 
incubated for 1 min in luminol reagent composed out of solution ECL1 and ECL2 in a 
ratio 1:1 (see table below). The membrane was then put between two transparent plastic 
foils and exposed to X-ray films for different time periods (typically 1sec, 5 sec, 15 sec, 
30 sec, 1 min, 5 min). 
 
ECL1 (30 ml 
final) 
100 mM Tris/HCl, pH 8.5, 300 µl luminol (440 mg/10 ml DMSO), 
132 µl p-cumaric acid (150 mg/10 ml DMSO) 
ECL2 (30 ml 
final) 
100 mM Tris/HCl, pH 8.5, 0.024 %  (w/v) H2O2 
 
 
2.6 Special Methods 
 
2.6.1 Mass spectrometry of elution fractions of Ni-NTA agarose pulldown 
In case the elution fractions of Ni-NTA agarose pulldown were to be analyzed by 
mass spectrometry, 12 mg of isolated mitochondria were applied. Otherwise, Ni-NTA 
pulldown was performed as decribed under 2.4.9. The gel was then stained with 
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Coomassie and whole lanes were manually excised and digested with trypsin at 30 °C 
overnight (Shevchenko et al., 2000; Wilm et al., 1996). In the Imhof laboraty, peptides 
from trypsin digest were injected in an Ultimate 3000 HPLC system (LC Packings) as 
described elsewhere (Forné et al., 2012). The drainage from the HPLC was injected by 
electrospray method into an LTQ-Orbitrap mass spectrometer (Thermo Fisher Scientific; 
“data dependent mode”).  The survey full scan MS spectra (from m/z 300 - 2000) were 
acquired with resolution R = 60,000 at m/z 400 (after accumulation to a target value of 
500000 in the linear ion trap). The 6 most intense peptide ions showing charging states of 
2 to 4 were sequentially isolated to a target value of 10000 and fragmented by collision 
induced dissociation (CID). They were collected and registered in the linear ion trap. For 
all Orbitrap measurements, 3 lock-mass ions were used for internal calibration (Olsen et 
al., 2005). The MS conditions were as follows: 1.5 kV spray voltage, 200 °C capillary 
temperature, 35 % normalized CID energy, activation q = 0.25, 30 msec activation time. 
Proteins were identified using Mascot version 2.3.02 (Database, Swissprot 57.10; 
Taxonomy, S. cerevisiae; MS tol, 10 ppm; MS/MS tol, 0.5 Da; peptide FDR, 0.1; protein 
FDR, 0.01; minimal peptide length, 5; variable modifications, oxidation (M); fixed 
modifications, carbamidomethyl). The fold-change of the proteins was quantified by 
applying spectral counting (Scaffold 3.0.9.1). Proteins that were used for quantification 
were filtered using 95.0 % peptide thresholds, 99.0 % protein thresholds and a minimum 
of 2 peptides. Proteins that showed at least five-fold enrichment in pulldown from 
mitochondria containing IMS-DHFRWT-His over mitochondria containing matrix-
DHFRWT-His or the empty plasmid were considered as potential interaction partners of 
IMS-DHFRWT-His. 
 
2.6.2 Identification of aggregating proteins by SILAC and mass spectrometry 
Wild-type YPH499 and Δyme1 strains were grown in medium containing normal and 
heavy lysine (Lys8: 13C615N2-L-Lysine•HCl, 13C6H1415N2O2). After isolation of 
mitochondria, ATP was depleted by adding 0.1 U/ml apyrase and 8 µM oligomycin and 
an aggregation assay was performed as described above. The aggregate fractions of wild-
type and Δyme1 mitochondria grown on heavy and light lysine, respectively, were pooled 
after the aggregation assay. In the other set of samples, aggregates from wild-type 
mitochondria isolated from cells grown on light lysine were mixed with aggregates from 
mitochondria isolated from Δyme1 cells grown on heavy lysine. Proteins were separated 
	   	   MATERIALS	  AND	  METHODS	  
 
	   57	  
by SDS-PAGE and stained in Coomassi. After in-gel digestion with Lys-C protease at 30 
°C over night, mass spectrometric analysis was performed as described in 2.6.1. 
Maxquant version 1.0.13.13 was combined with Mascot version 2.3.02 for identification 
and quantification of proteins. The conditions for Mascot protein identification were as 
described above. The conditions for Maxquant were: peptides for protein quantification = 
1, unique and razor = 1, 1 peptide minimum, 2 min ratio count, multiplicity = 2, heavy 
labels = Lys8. Mitochondrial proteins that showed in at least two out of four independent 
experiments a 1.6-fold or higher aggregation in mitochondria lacking Yme1 compared to 
wild-type mitochondria (SILAC ratios of at least two different peptides) were included 
and considered as potential substrate candidates of Yme1. 
 
 
2.7 Chemicals, consumables and equipment 
 
2.7.1 Chemicals 
Compound Source/ Company 
Acrylamide-Bisacrylamide Serva 
Agarose (for electrophoresis) Serva 
Acetic acid (C2H4O2) AppliChem 
Adenine Sigma-Aldrich 
Amino acids (His, Lys, Leu, Trp) Sigma-Aldrich 
Ampicillin AppliChem 
Adenosine diphosphate (ADP) Roche 
Adenosine triphosphate (ATP) Roche 
Apyrase Sigma-Aldrich 
Bacto-peptone Becton-Dickinson 
β-Mercaptoethanol Sigma-Aldrich 
Bradford Reagent Bio-Rad 
Bromophenol blue Roth 
BSA Roth 
BSA, fatty acid-free Serva 
CaCl2 (calcium chloride) Merck 
Citric acid (C6H8O7) Serva 
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Coomassi Brilliant Blue, CBB R-250 Serva 
Cytochrome c Sigma-Aldrich 
Creatine kinase (CK) Roche 
Creatine phosphate (CP) Sigma-Aldrich 
P-Cumaric acid Sigma-Aldrich 
Dimethyl sulfoxide (DMSO) Roth 
Dithiotreitol (DTT) Roth 
dNTPs New England Biolabs 
Dry milk powder Spinnrad 
Ethanol Sigma-Aldrich 
Ethidium bromide Serva 
Freund’s Adjuvans (incomplete) Sigma-Aldrich 
D-Galactose Sigma-Aldrich 
Gel extraction kit (DNA) Promega 
Glycerol Sigma-Aldrich 
Goat Anti-Mouse / -Rabbit Bio-Rad 
H2O2 AppliChem 
Hepes Serva 
Hydrochloric acid (HCl) AppliChem 
Imidazole AppliChem 
IPTG (isopropyl β-D-1-thiogalactopyranoside) Serva/ Merck 
KCl (potassium chloride) Merck 
KH2PO4 (potassium dihydrogen phosphate) Merck 
Lactic acid (C3H6O3) Merck 
Lithium acetate Sigma-Aldrich 
L-Lysine-13C6, 15N2 hydrochloride Sigma-Aldrich 
Luminol Sigma-Aldrich 
Lysozyme Serva 
Milk powder Spinnrad 
MgCl2 (magnesium chloride) Merck 
MgSO4 (magnesium sulfate) AppliChem 
MnCl2 (manganese chloride) Merck 
NaCl (sodium chloride) Merck 
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NADH (nicotinamide adenine dinucleotide) Serva 
NaOH (sodium hydroxide) ThermoFisher Scientific 
Na2HPO4 (di-sodium hydrogen phosphate) Merck 
NaO2C2H3 (sodium acetate) Merck 
NaO3 (sodium nitrate) Serva 
N2O8S2H8 (ammonium peroxo disulfate) Serva 
NH4Cl (ammonium chloride) Merck 
(NH4)2SO4 (ammonium sulfate) Merck 
Ni-NTA agarose Qiagen 
Oligomycin Sigma-Aldrich 
Pfu polymerase New England Biolabs 
PMSF (phenylmethansulfonyl fluoride) Serva 
Ponceau S solution Sigma-Aldrich 
Protease Arrest Reagent Calbiochem 
Proteinase K (PK) Roche 
Restriction enzymes New England Biolabs 
RNasin New England Biolabs 
Sodium dodecyl sulfate (SDS) Serva 
D-Sorbitol Sigma-Aldrich 
S35-methionine MP Biomedicals 
SulfoLink Resin Pierce/ ThermoFisherScientific 
T4 DNA ligase New England Biolabs 
T4 ligation buffer (10x) New England Biolabs 
Taq polymerase New England Biolabs 
TEMED (tetramethylethylenediamine) Serva 
Titermax Gold Sigma-Aldrich 
Tris, buffer grade AppliChem 
Triton X-100 Sigma-Aldrich 
Unstained Protein Marker Fermentas/ ThermoFisherScientific 
Uracil Sigma-Aldrich 
Urea Serva 
Valinomycin Sigma-Aldrich 
Yeast extract Serva 
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Yeast nitrogen base Invitrogen/ Life technologies 
Zymolyase 20T Seikagaku Biobusiness 
 
2.7.2 Consumables 
Item Source/ Company 
Blotting paper NeoLab 
Filters (sterile) Schleicher & Schüll 
Gloves (Latex, Nitrile) Semper care 
Nitrocellulose membrane Whatman 
PCR tubes Peqlab 
Petri dishes Sarstedt 
Pipette tips (10 - 1000 µl) Sarstedt 
1.5 ml reaction tubes Sarstedt 
2 ml reaction tubes Sarstedt 
15 ml reaction tubes Greiner 
50 ml reaction tubes Greiner 
Semi micro-cuvettes Greiner 
Super RX films Fujifilm 
X-ray films Biomax MR Kodak 
 
2.7.3 Equipment 
Item Source/ Company 
Accu-jet  Brand 
Balance CP2202S Sartorius 
Balance XS205 Mettler Toledo 
Centrifuge Avanti J-25/ J-20 XP Beckman 
Centrifuge Benchtop Allegra X-22R Beckman 
CentrifugeTable Top 5415D Eppendorf 
Centrifuge Ultracentrifuge optima MAX-E Beckman 
Developing machine CURIX60 AGFA 
Electroporation system “Gene Pulser” Bio-Rad 
Gel imaging system “GelDoc-It” UVP 
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Horizontal rotary shaker made in house  
PCR cycler “Mastercycler gradient” Eppendorf 
Pipettes, 10 µl - 5000 µl Gilson 
Sonifier 250 Branson 
Spectrophotometer Nanodrop 2000c Peqlab 
Thermomixer “comfort” Eppendorf 
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3.  RESULTS 
 
3.1 Generation and characterization of model substrates for      
      investigating folding in the mitochondrial intermembrane space 
 
3.1.1 Generation of an IMS-targeted Cytochrome b2-DHFR model substrate  
A well studied mouse protein was chosen as model substrate for the investigations. 
Mus musculus DHFR is essential for nucleotide biosynthesis in mouse. It catalyzes the 
reduction of dihydrofolic acid to tetrahydrofolic acid, using NADPH as an electron donor 
(Gangjee et al., 2009). Mature DHFR attains a very compact structure that can be further 
stabilized by the substrate analogue methotrexate (Junker et al., 2005). DHFR is 
frequently used to study import into and folding in isolated yeast mitochondria (Eilers and 
Schatz, 1986; Pfanner et al., 1987; Gruhler et al., 1995; Kanamori et al., 1997; Gaume et 
al., 1998).  
DHFR was fused behind a targeting sequence derived from the endogenous yeast 
protein cytochrome b2 (Cyb2). A bipartite presequence targets Cyb2 to the mitochondrial 
intermembrane space (Beasley et al., 1993). The typical N-terminal matrix-targeting 
signal directs the precursor of Cyb2 emerging from cytosolic ribosomes to the 
translocases of the outer and inner mitochondrial membrane, the TOM complex and the 
TIM23 complex. A stop-transfer signal is located C-terminally to the matrix-targeting 
signal and leads to the arrest of translocation at the level of the inner membrane. 
Subsequently, TIM23 opens laterally and releases the precursor protein into the lipid 
bilayer of the inner mitochondrial membrane. Matrix processing peptidase (MPP) cleaves 
off the matrix targeting signal (Yang et al., 1988) and the mitochondrial inner membrane 
protease (IMP) cleaves the precursor at the intermembrane space side of the inner 
membrane (Pratje and Guiard, 1986; Geissler et al., 2000). Consequently, the mature 
Cyb2 is released as soluble protein into the intermembrane space. DHFR was fused to 
amino acid residues 1-107 of the Cyb2 precursor including the bipartite presequence via a 
short glycine linker. The resulting construct was named IMS-DHFRWT (Fig. 5). In order 
to generate a matrix-targeted control protein, the stop-transfer signal was deleted from  
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the Cyb2 presequence (1-107; Δ19). The resulting hybrid protein, matrix-DHFRWT, should 
not be arrested at the level of the inner membrane but fully translocated into the matrix. 
Two further model substrates containing a mutant version of DHFR were created. Three 
point mutations (S7C/C42S/C49N) generate a folding incapable version of DHFR 
(Vestweber and Schatz, 1988). This mutant version of DHFR was fused to both Cyb2 
presequences, generating the two mutant hybrid proteins IMS-DHFRmut and matrix-
DHFRmut. The inserts coding for the four model substrates (Fig. 5) were cloned into the 
yeast expression vector pYES2 and transformed into YPH499 wild-type yeast strain. 
Expression of the model substrates was induced by activation of the GAL promoter on the 
pYES2 plasmid. The expected submitochondrial localization of the model substrates is 
depicted in Figure 6. 
Figure 5. Schematic representation of the model substrates 
Wild-type (WT) and non-folding mutant (mut; C7S, S42C, N49C) versions of mouse 
DHFR were fused C-terminally to amino acid residues 1-107 of yeast cytochrome b2 
targeting it to the intermembrane space (IMS-DHFR). Constructs with deleted stop-
transfer signal should target to the matrix (matrix-DHFR). p, bipartite targeting signal of 
cytochrome b2; cleavage by the mitochondrial processing peptidase (MPP) leads to the 
intermediate sized i-form; cleavage by the inner membrane peptidase (IMP) leads to the 
mature m-form. 
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3.1.2 Optimization of induction of model substrate expression 
The time point for induction of the expression was then optimized. For this purpose, 
yeast cells harboring IMS-DHFRWT or matrix-DHFRWT on the pYES2 plasmid were 
grown for three to four doubling times in the logarithmic phase. Subsequently, one 
aliquot of cells was induced in the logarithmic growth phase (OD600 0.6) and a second 
aliquot was induced in the stationary growth phase (OD600 0.9). Samples of the cells 
before and after induction were withdrawn, solubilized with NaOH and the expression 
levels of the DHFR constructs were analyzed by SDS-PAGE, western blot, and immuno-
staining. The efficiency of induction was very low when the promoter was activated in 
the stationary phase (Fig. 7, lanes 3+4, 7+8). Additionally, a significant background 
expression occurring without activation of the promoter was observed when cells were 
grown in the stationary phase. In contrast, during logarithmic growth, no background 
expression was detected and induction of the expression occurred with high efficiency 
(Fig. 7, lanes 1+2, 5+6).  
Therefore, in further experiments, cells were kept in the logarithmic growth phase 
(OD600 0.6) and expression of the model substrates was also induced in this growth phase. 
Figure 6. Overview of the predicted submitochondrial localization of the model 
substrates 
Wild-type (WT) and non-folding mutant (mut) versions of DHFR were fused to Cyb2(1-
107) or Cyb2(1-107; Δ19) to target them to the intermembrane space, IMS (red) and the 
matrix (blue), respectively. 
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3.1.3 Expression of model substrate in S. cerevisiae 
Expression of the four model substrates was induced by activation of the GAL 
promoter and monitored over 120 minutes. Samples of the cultures were taken at different 
time points and total cell extracts were analyzed by SDS-PAGE, western blot and 
immuno-staining. The expression levels of the model substrates increased during time 
after induction (Fig. 8 A-D). The expression levels of the wild-type model substrates were 
slightly higher than the expression levels of the mutant model substrates (Fig 8 A, D). 
Moreover, the expression levels of matrix-DHFR were generally higher than in the 
intermembrane space (Fig. 8 C, D). In conclusion, these findings confirm that the model 
substrates can be stably expressed upon activation of the promoter and that the expression 
increases with time after activation. The lower expression levels of the folding incapable 
mutant DHFR constructs may be caused by their increased degradation. The lower 
expression levels in the intermembrane space could be attributed to a higher turnover of 
the overexpressed model substrates in this compartment. The volumetric capacity of the 
intermembrane space is low and therefore, this increased turnover of the overexpressed 
model substrates could prevent their aggregation. Unrelated yeast proteins of the cytosol 
(hexokinase) and the inner membrane (Tim17) were analyzed as controls. Neither of them 
Figure 7. Optimization of model substrate expression 
Two sets of yeast cells harboring IMS- or matrix-DHFRWT in pYES2 plasmid were grown 
in parallel and expression was induced in the logarithmic (log) phase (OD600 0.6) in one 
set and in the stationary (OD600 0.9) phase (stat) in the other set by activation of GAL 
promoter. Cells were harvested after two hours induction, disrupted with NaOH and 
expression levels were analyzed by immuno-staining with antibodies for indicated 
proteins. p, precursor, i, intermediate and m, mature forms of the DHFR constructs. 
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was affected by the expression of the model substrates. In further experiments, expression 
of the model substrates was always induced for 120 minutes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.4 Verification of the steady state levels of endogenous proteins in cells  
         expressing the model substrates  
Possible side effects of the expression of the model substrates on the integrity of 
mitochondria were investigated. For this purpose, the steady state levels of a number of 
unrelated proteins from the four mitochondrial subcompartments were analyzed in 
mitochondria isolated from cells expressing the model substrates. None of the tested 
proteins of the outer membrane (Tom22), the intermembrane space (Cyb2), the inner 
membrane (Tim50) and the matrix (Ssc1) were affected by the expression of the model 
substrates (Fig. 9). The expression levels of the endogenous proteins were 
indistinguishable among the four types of mitochondria. 
Figure 8. Kinetics of model substrate expression 
Expression of model substrate was induced in the logarithmic growth phase and samples 
of cells taken at indicated time points. Cells were disrupted by the Rödel’s cell lysis and 
the expression levels of IMS-DHFR (A, B) and matrix DHFR (C, D) constructs were 
analyzed by immuno-staining for indicated proteins. i, intermediate and m, mature form 
of IMS-DHFR constructs. 
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In conclusion, this shows that all four mitochondrial subcompartments remain 
evenutally unaffected by expression of the model substrates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.5 Subcellular localization of model substrates expressed in vivo   
In order to analyze the subcellular localization the model substrates, fast 
mitochondrial isolation was performed from cells expressing IMS-DHFRWT or matrix-
DHFRWT. Unbroken cells, cell debris and nuclei were removed and the crude 
mitochondrial fraction (M) was separated from the crude cytosolic fraction (C). The four 
model substrates were only detected in the crude mitochondrial fraction similar to the 
mitochondrial marker proteins Tom40 and Tim17 (Fig. 10, lanes 1+3). In contrast, the 
cytosolic marker protein Bmh2 was only detected in the cytosolic fraction (Fig. 10, lanes 
2+4).  
In summary, this shows that the model substrates are translocated into mitochondria 
and do not accumulate in the cytosol. 
Figure 9. Steady-state levels of endogenous mitochondrial proteins in cells 
expressing the model substrates 
Mitochondria were isolated and analyzed by SDS-PAGE, western blot and immuno-
staining using antibodies against the indicated proteins. i, intermediate and m, mature 
form of IMS-DHFR constructs. 
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3.1.6 Submitochondrial localization of the model substrates 
The submitochondrial localization of the model substrates expressed in S. cerevisiae 
was determined by digitonin fractionation. The outer and the inner mitochondrial 
membrane were opened sequentially by increasing concentrations of digitonin as judged 
by the accessibility of marker proteins of the outer membrane (Tom70), the inner 
membrane (Tim50) and the matrix (Hep1). Externally added protease, proteinase K (PK), 
degraded outer membrane proteins first and then proteins of the intermembrane space and 
the inner membrane. Eventually, the matrix proteins were degraded upon disruption of 
the inner membrane. IMS-DHFRWT and IMS-DHFRmut behaved similar to Tim50, an 
inner membrane protein with a large domain protruding into the intermembrane space 
(Fig. 11A, C). This finding confirms that both IMS-targeted model substrates are indeed 
localized in the intermembrane space. Similarly to the matrix protein Hep1, matrix-
DHFRWT and matrix-DHFRmut were protected against proteinase K digestion until the 
inner membrane was disrupted. This finding demonstrates that the two matrix-targeted 
model substrates are also localized correctly (Fig. 11B, D). 
Collectively, these findings show that all four DHFR constructs were sorted to the 
expected mitochondrial subcompartment. 
Figure 10. Subcellular 
localization of the DHFR 
constructs 
Crude mitochondrial fraction 
(M) and remaining cellular 
components (C) from cells 
expressing the model 
substrates were analyzed by 
SDS-PAGE and immuno-
staining using antibodies 
against the indicated 
proteins. i, intermediate and 
m, mature form of IMS-
DHFR. 	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Figure 11. Submitochondrial localization of model substrates 
Mitochondria were incubated with increasing amounts of digitonin (0.005 – 0.1 %) in the 
presence of proteinase K (PK) for 25 min on ice. Samples were analyzed by SDS-PAGE, 
western blot and immuno-staining using antibodies against DHFR and the indicated 
mitochondrial marker proteins (Tom70, outer membrane; Tim50, intermembrane space; 
Hep1, matrix). i, intermediate and m, mature form of IMS-DHFR constructs. Localization 
of wild-type (A, B) and mutant (C, D) constructs. 
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3.2 Investigation of the folding behavior of the model substrates 
 
3.2.1 In vivo protease resistance in the absence and presence of methotrexate 
Protease treatment of DHFR had previously been shown to yield a stable fragment of 
roughly 25 kDa (Gaume et al., 1998). In order to determine the folding state of in vivo 
expressed model substrates, their stability was tested upon protease treatment. For this 
purpose, isolated mitochondria from cells expressing the model substrates were 
solubilized and treated with proteinase K. The wild-type model substrates were partly 
degraded upon addition of the protease and a protease-resistant fragment of roughly 25 
kDa was generated (Fig. 12, left panel, lane 2). In contrast, the mutant versions of the 
model substrates were entirely degraded (Fig. 12, right panel, lane 2) (Vestweber and 
Schatz, 1988). In presence of the DHFR substrate analog methotrexate, the wild-type 
model substrates were stabilized even further, and thus the levels of the stable fragment 
increased (Fig. 12, left panel, lane 3). This finding can be explained by binding of 
methotrexate to wild-type DHFR, which in turn leads to further stabilization of the native 
fold. Neither of the mutant forms was stabilized by methotrexate (Fig. 12, right panel, 
lane 3) because the substrate analog cannot bind to unfolded DHFR. 
In conclusion, these results show that the wild-type DHFR constructs assume their 
native fold in the mitochondrial intermembrane space and in the matrix.  
 
 
 
Figure 12. Folding of model substrates in the presence and absence of 
methotrexate 
Isolated mitochondria were solubilized with Triton X-100 and incubated with proteinase K 
(PK) for 20 min at 0 °C in the presence and absence of methotrexate (Mtx). Samples were 
analyzed by SDS-PAGE and immuno-staining with antibodies against DHFR. i, intermediate 
and m, mature form of IMS-DHFR. sf, stable fragment upon protease digestion. 
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3.2.2 Requirements for folding of DHFR in the IMS and matrix 
Next, it was asked if nucleotides and heat stress have an effect on the folding state of 
the DHFR constructs. To this end, one set of isolated mitochondria from cells expressing 
the model substrates was depleted of nucleotides. The ATP levels of a second set of these 
mitochondria were kept high. Both sets were subjected to a short heat shock at 42 °C for 
3 min. One set of samples was kept at 25 °C as a control. After solubilization of the 
mitochondria with Triton X-100, pellet and supernatant fractions, representing aggregated 
and soluble proteins, were separated by centrifugation. At 25 °C, IMS-DHFRWT was 
found in the soluble fraction in the presence and absence of ATP (Fig. 13 A, lanes 1-4). 
However, upon heat shock, the mature (m) form of IMS-DHFRWT aggregated in an ATP-
dependent manner (Fig. 13 A, lanes 5-8). In the presence of ATP, 14 % of IMS-DHFRWT 
aggregated (Fig. 13 A, lane 7). In the absence of ATP, aggregation increased to 89 % 
(Fig. 13 A, lane 5). The intermediate (i) form of IMS-DHFRWT, which is not yet cleaved 
by inner membrane peptidase and is thus still anchored to the inner membrane, 
aggregated almost completely upon heat shock (99 %) (Fig. 13 A, lanes 5+7).  
Matrix-DHFRWT also aggregated in an ATP-dependent manner upon heat shock (Fig. 
13 B, lanes 5-7). However, only a much smaller proportion (1 % or 3 %) than in the 
intermembrane space aggregated in the matrix upon heat shock (Fig. 13 B, lanes 5+7). 
This could be attributed to a higher capacity of the protein quality control systems of the 
matrix than of the ones in the intermembrane space.  
 
 
Figure 13. Aggregation of wild-type DHFR constructs in IMS and matrix 
Isolated mitochondria were incubated under the indicated conditions, solubilized with 
Triton X-100, and soluble (S) and aggregate (P, pellet) fractions were separated by 
centrifugation and analyzed by SDS-PAGE and immuno-staining for indicated proteins. 
Singals of wild-type IMS-DHFR (A) and matrix-DHFR (B) were quantified in supernatant 
and pellet fractions and expressed as percentages of total protein. ND, not detectable. i, 
intermediate and m, mature form of IMS-DHFR. 
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IMS-DHFRmut aggregated under all tested conditions (Fig. 14 A), even in the presence of 
ATP under physiological conditions (Fig. 14 A, lane 3). Matrix-DHFRmut behaved similar 
to matrix-DHFRWT (Fig. 14 B), although aggregation upon heat shock was slightly 
increased in comparison to the wild-type counterpart (Fig. 14 B, lanes 5+7). In the 
presence of ATP, only 10 % of matrix-DHFRWT aggregated upon heat shock (Fig. 4, lane 
7). This is in agreement with the ATP-dependent activity of the chaperones of the protein 
quality control system in the mitochondrial matrix. 
 
Collectively, these results show that, under stress conditions, the stability of DHFR is 
determined by an ATP-dependent process. This applies to the wild-type constructs in the 
intermembrane space and in the matrix. Furthermore, it becomes clear that the capacity of 
the protein quality control system in the matrix is higher than the capacity of the protein 
quality control system in the intermembrane space. The unfolded DHFRmut construct was 
kept soluble in the matrix whereas its counterpart in the intermembrane space aggregated 
even under physiological conditions.  
 
Figure 14. Aggregation of DHFRmut in IMS and matrix 
 Isolated mitochondria were incubated under conditions to increase or decrease the 
mitochondrial ATP levels and then exposed to 25°C or 42°C for three minutes. 
Mitochondria were then solubilized with Triton X-100-containing buffer and soluble (S) 
and aggregate (P, pellet) fractions separated by centrifugation and analyzed by SDS-
PAGE and immuno-staining using antibodies against the indicated proteins. The DHFR 
signals were quantified in the supernatant and pellet fractions and expressed as 
percentages of total protein. ND, not detectable. i, intermediate and m, mature form of 
IMS-DHFR. 
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3.3 Identification of potential folding helpers of DHFR in the IMS 
 
3.3.1 Ni-NTA pulldown and label-free quantification by mass spectrometry 
Having confirmed that wild-type DHFR assumes its native fold in the intermembrane 
space, it should be investigated, which folding helpers guide this process. For this 
purpose, the binding partners of DHFR in the intermembrane space needed to be 
determined. Yeast strains expressing a C-terminally His-tagged version of wild-type IMS- 
and matrix-DHFR were employed. Mitochondria isolated from cells expressing IMS-
DHFRWT-His or matrix-DHFRWT-His were solubilized with digitonin and the His-tagged 
model substrates were captured with Ni-NTA agarose beads. Mitochondria harboring 
empty pYES2 vector served as a control. The eluate fractions from the agarose beads 
were subjected to SDS-PAGE, excised from the gel and analyzed by mass spectrometry 
(Fig. 15). Three proteins were specifically co-isolated with IMS-DHFRWT-His: Yme1, 
Mgr1, and Mgr3. Yme1 is the AAA protease of the mitochondrial intermembrane space 
mediating the turnover of inner membrane and intermembrane space proteins (Nakai et 
al., 1995; Pearce and Sherman, 1995; Weber et al., 1995; Lemaire et al., 2000; Kominsky 
et al., 2002; Augustin et al., 2005; Graef et al., 2007; Osman et al., 2009a; Tamura et al., 
2009; Potting et al., 2010). Mgr1 and Mgr3 have recently been shown to form a 
supermolecular complex with Yme1 (Dunn et al., 2006; Dunn et al., 2008). Furthermore, 
Mgr1 and Mgr3 have been suggested to function as adaptors of Yme1 (Dunn et al., 2008; 
Graef et al., 2007; Osman et al., 2009; Potting et al., 
2010). 
 
 
 
 
 
 
 
 
Figure 15. Workflow of Ni-
NTA-pulldown and mass 
spectrometry 
Upon Ni-NTA pulldown and 
isolation of His-tagged DHFR 
constructs, samples were 
separated by SDS-PAGE. 
Proteins in the elution fractions 
were excised, digested with 
trypsin and tryptic fragments 
were quantitatively analyzed by 
label-free mass spectrometry 
(MS).  
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3.3.2 Confirmation of Ni-NTA pulldown by western blot and immuno-staining 
The results of the mass spectrometric analysis were confirmed with an unrelated 
method. For this purpose, Ni-NTA pulldown was performed as described above. This 
time, mitochondria were pretreated with ATP-depleting system, ATP-regenerating system 
or ADP prior to solubilization. Samples of the mitochondrial lysates (total) and the 
eluates (bound) were analyzed by SDS-PAGE, western blot and immuno-staining. Yme1 
was specifically co-isolated with IMS-DHFRWT-His (Fig. 16, lanes 11, 14), but not with 
matrix-DHFRWT-His (Fig. 16, lanes 12, 15, 18). Notably, Yme1 was only co-isolated in 
the absence of nucleotides or in the presence of ADP (Fig. 16, ‘ID’ in ‘-/ADP-bound’). In 
the presence of ATP, Yme1 was not co-isolated (Fig. 16, ‘ID’ in ‘ATP/bound’). These 
findings agree with the typical behaviour of chaperone-substrate interactions. The 
interaction is typically stabilized by ADP or in the absence of nucleotides, as the substrate 
can bind to the chaperone but is not processed. In the presence of ATP, the interaction is 
shorter as the substrate is processed and released very quickly. Therefore, the interaction 
is not easy to detect. Importantly, the two matrix chaperones Hsp70 (Ssc1) and Hsp60 
Figure 16. Identification of potential folding helpers of IMS-DHFR 
Isolated mitochondria were solubilized with digitonin-containing buffer in the absence of 
nucleotides or in the presence of ATP or ADP. Samples were incubated with Ni-NTA 
agarose beads and specifically bound proteins eluted with Laemmli buffer containing 
500mM imidazol. Total (10 %), and bound (100 %) fractions were analyzed by SDS-
PAGE and immuno-staining for the indicated proteins. ID, IMS-DHFR, mD, matrix-
DHFR, i, intermediate and m, mature form of IMS-DHFR. 
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were specifically co-isolated with matrix-DHFRWT-His in the absence of ATP. This is in 
line with former studies reporting that Hsp70 and Hsp60 are involved in the folding of 
DHFR in the matrix (Gaume et al., 1998; Ostermann et al., 1989). 
Collectively, these experiments demonstrate an ATP-dependent interaction of IMS-
DHFRWT with Yme1. This suggests that Yme1 could function as a chaperone for DHFR 
in the intermembrane space. 
 
 
3.4 Generation and characterization of Yme1 deletion strain 
 
3.4.1 Growth phenotype of Δyme1 strain  
To analyze a potential chaperone-like function of Yme1, YME1 was deleted in the 
YPH499 background and the growth behavior of the deletion strain was analyzed. The 
YME1 locus was replaced by a kanamycin cassette using homologous recombination. The 
growth behavior of the deletion strain was analyzed at different temperatures on 
fermentable (YPD) and non-fermentable (YPG) medium. A general growth defect of 
Δyme1 strain was observed on non-fermentable medium, irrespective of the growth 
temperature (Fig. 17, left panel). The deletion of Yme1 induced a temperature-sensitive 
growth defect on fermentable medium at high (37 °C) and low (14 °C) temperature (Fig. 
17 right panel). These observations differ slightly from the findings of previous studies on 
the YME1 deletion strain. These studies report a growth defect only on non-fermentable 
medium at 37 °C and on fermentable medium at 14 °C (Thorsness et al., 1993; Thorsness  
 
 
Figure 17. Growth 
phenotype of Δyme1 
Wild-type and Δyme1 strain 
were grown for three days in 
YPGal. Five serial dilutions 
of cell suspension were 
prepared. 2 µl of each 
dilution were spotted on 
YPG and YPD plates. The 
plates were incubated at the 
indicated temperatures. WT, 
wild-type. 
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and Fox, 1993). The likely reason for this discrepancy is that in the present study a 
different background strain for the YME1 deletion. There are studies confirming that the 
background strain can affect the phenotype of particular deletions to a large extent (Dunn 
et al., 2008). 
 
3.4.2 Mitochondrial DNA in Δyme1 strain 
In order to analyze the presence of mitochondrial DNA in the Δyme1 strain, PCR 
was performed on the mitochondrially encoded gene ATP8. Δhep1, a strain (Burri et al., 
2004)lacking mitochondrial DNA (rho0) was analyzed as a control. The PCR fragment of 
ATP8 was detected in both wild-type and Δyme1 strains but not in the Δhep1 strain (Fig. 
18). In conclusion, this result demonstrates that the Δyme1 strain does not lose its entire 
mitochondrial genome although an elevated rate of mitochondrial DNA escape to the 
nucleus had been reported in previous studies (Thorsness et al., 1993; Thorsness and Fox, 
1993). 
 
 
 
3.5 Behavior of the model substrate in the absence of Yme1 
 
3.5.1 Expression of model substrates in Δyme1 strain 
To address the role of Yme1 in folding of DHFR in the IMS, IMS-DHFRWT and 
matrix-DHFRWT were expressed in the Δyme1 strain. The steady state levels of the model 
substrates were analyzed in isolated mitochondria by SDS-PAGE, western blot and 
immuno-staining. Interestingly, the steady levels of IMS-DHFRWT were approximately 
two-fold higher in the Δyme1 strain than in the wild-type strain (Fig. 19, lanes 1-4). The 
expression levels of matrix-DHFRWT, however, were indistinguishable between deletion 
and wild-type strain (Fig 19, lanes 5-8). This is in agreement with previous studies which 
Figure 18. Mitochondrial DNA of 
Δyme1 
PCR on mitochondrially encoded 
ATP8 was performed in WT, Δyme1 
and Δhep1 strains. Amplified DNA 
was visualized under UV light. water 
control, control. WT, wild-type. 
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show that DHFR is a proteolytic substrate of Yme1 (Leonhard et al., 1999), and supports 
the idea of a specific role of Yme1 in the biogenesis of IMS-DHFR. 
 
 
 
3.5.2 Effect of Yme1 on the folding of DHFR 
Folding of IMS-DHFRWT was analyzed in mitochondria lacking Yme1. For this 
purpose, isolated mitochondria were depleted from ATP, solubilized and soluble and 
aggregate fractions were separated by centrifugation. In the absence of Yme1, a large 
proportion of IMS-DHFRWT was found in the aggregate fraction even under physiological 
conditions (Fig. 20 A, left panel, lane 1). This finding underlines that Yme1 is not only 
involved in degradation of DHFR, but likely also plays a role in folding DHFR in the 
intermembrane space. Interestingly, the intermediate form of IMS-DHFRWT that is 
processed only once shows a stronger dependancy on Yme1 than the mature form (Fig. 
20 A, left panel, lane 1). A possible explanation for this observation is that the 
membrane-anchor of the intermediate form slows down the folding of the mature part of 
the protein. Therefore, the intermediate form needs more intensive chaperone assistance. 
Importantly, the deletion of YME1 had no effect on the folding of matrix-DHFRWT (Fig. 
20 B, left panel, lanes 1+2). Matrix-DHFRWT was only detected in the soluble fraction in 
the presence and absence of Yme1 (Fig. 20 B, both panels).  
Figure 19. Expression of DHFR constructs in Δyme1  
Steady-state levels of isolated mitochondria (5 and 15 µg) from cells expressing the model 
substrates were analyzed by SDS-PAGE and immuno-staining for indicated proteins. i, 
intermediate and m, mature form of IMS-DHFR. WT, wild-type. 
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In conclusion, these experiments demonstrate that Yme1 is not only involved in 
degradation of DHFR but strongly suggests a role of Yme1 in the folding of DHFR in the 
intermembrane space. 
 
 
 
3.6 Identification of endogenous Yme1 substrates  
 
3.6.1 Identification of proteins that aggregate in the absence of Yme1 by SILAC        
         and mass spectrometry 
Next, endogenous substrates of the chaperone-like activity of Yme1 should be 
determined and analyzed. For this purpose, wild-type and Δyme1 cells were grown in 
medium containing heavy or light lysine (Fig. 21). Mitochondria were isolated, aggregate 
fractions were collected and mixed from both strains of mitochondria in a way that one 
strain is labeled with heavy lysine and the other strain is labeled with light lysine (Fig. 
21). The combined aggregate fractions were subjected to SDS-PAGE and proteins were 
digested ‘in gel’ with the protease Lys-C. In collaboration with the Imhof laboratory 
(Zentrum für Proteinanalytik, Munich), the peptides resulting from Lys-C treatment were 
subsequently analyzed by mass spectrometry (Fig. 21).  
Figure 20. Aggregation of DHFR constructs in the YME1 deletion strain 
Mitochondria of cells expressing IMS-DHFRWT (A) or matrix-DHFRWT (B) were solubilized in 
Triton X-100-containing buffer and soluble, S, and aggregate, P (pellet), fractions were 
separated by centrifugation. Samples were analyzed by SDS-PAGE followed by western blot 
and immuno-staining for indicated proteins. i, intermediate and m, mature form of IMS-DHFR. 
WT, wild-type. 
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Two biological and four technical replicates were analyzed and proteins that showed 
at least 1.6-fold higher aggregation in mitochondria lacking Yme1 than in mitochondria 
from the wild-type strain were classified as potential substrate proteins of the chaperone-
like activity of Yme1. The list of mitochondrial proteins that fulfilled these criteria is 
given in Table 1. Among the identified potential Yme1 substrates are predominantly 
proteins that reside in the intermembrane space or the inner membrane. Among them 
were Ups2, an intermembrane space protein that is involved in mitochondrial lipid 
metabolism (Osman et al., 2009; Tamura et al., 2009; Tamura et al., 2012), three 
components of the dehydrogenase complex of the intermembrane space, Nde1, Dld1 and 
Figure 21. SILAC and mass spectrometry setup - a schematic overview 
Wild-type and Δyme1 strain were grown in medium containing heavy or light lysine. 
Mitochondria were isolated, aggregate and soluble fractions separated, mixed from both 
types of mitochondria and subjected to SDS-PAGE. Peptides resulting from Lys-C 
digestion of gel slices from SDS-PAGE were analyzed by mass spectrometry. 
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Gut2 (Augustin et al., 2005; Grandier-Vazeille et al., 2001), prohibitins, protein scaffolds 
of the inner membrane (Osman et al., 2009; Steglich et al., 1999) and Cox2, an essential 
component of the respiratory chain in the inner membrane (Nakai et al. 1995; Pearce and 
Sherman, 1995; Taanman and Capaldi, 1992; Weber et al., 1996). Ups2, Nde1 and Cox2 
were previously shown to represent the proteolytical substrates of Yme1 (Nakai et al., 
1995; Dunn et al., 2008; Potting et al., 2010). Most of the proteins of the mitochondrial 
matrix that were identified in the SILAC screen belong to the chaperone family, and the 
intrinsic aggregation propensity of members of this protein family is significantly higher 
compared to non-chaperone proteins. This could explain why these matrix-located 
proteins were found in the screen.  
Notably, the identified proteins of the intermembrane space and the inner membrane 
are not uniform. They belong to different structural and functional classes. This 
observation suggests that Yme1 is not only important for a subset of proteins. It instead 
seems to have broad substrate specificity. The fact that the identified proteins aggregate 
in the absence of Yme1 indicates that Yme1 is not only involved in the degradation of 
these substrates, but also has a crucial function in their folding. The identification of 
previously known substrates confirms the method and strongly suggests that additional 
identified proteins are also true Yme1 substrates. 
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Table1. Proteins that aggregate in Δyme1 mitochondria 
Wild-type and Δyme1 cells were grown in medium containing light or heavy lysine. 
Mitochondria were isolated and soluble and aggregate fractions separated by 
centrifugation as described before. After SDS-PAGE, aggregate fractions were excised 
from the gel and loaded on Orbitrap mass spectrometer. Two biological replicates were 
analyzed. Table 1 contains alphabetically sorted mitochondrial proteins that showed at 
least 1.6 fold higher aggregation propensity in mitochondria lacking Yme1 in at least 
two of the experiments. Only proteins with at least two different quantified peptides 
were considered. SL, submitochondrial localization; TM, transmembrane domains; CF, 
cofactor; SL/TM/CF according to the Uniprot database (www.uniprot.org); function 
according to the SGD database (www.yeastgenome.org). 
 
 ORF Protein SL TM CF Function 
1 Q0250 COX2 IM-
IMS 
2 copper subunit II of cytochrome c 
oxidase, mitochondrially-
encoded  
2 YAL039C CYC3 IMS - heme, 
iron 
cytochrome c heme lyase 
(holocytochrome c synthase), 
attaches heme to apo-
cytochrome c in the IMS 
3 YBL095W - not 
known 
1  - unknown 
4 YBR262C AIM5 IM-
IMS 
1 - subunit of mitochondrial IM 
organizing system (MitOS/ 
MICOS/ MINOS), role in 
maintenance of crista 
junctions and IM architecture 
5 YBR282W MRPL27 matrix - - mitochondrial protein of the 
large ribosomal subunit 
6 YCL044C MGR1 IM-
IMS 
2 - subunit of mitochondrial i-
AAA protease that degrades 
misfolded mitochondrial 
proteins, binds to substrates 
to facilitate proteolysis, 
required for growth of rho0 
cells 
7 YCR071C IMG2 matrix - - mitochondrial ribosomal 
protein of the large subunit 
8 YDL174C DLD1 IM-
IMS 
1 FAD, 
zinc 
D-lactate dehydrogenase, 
oxidizes D-lactate to 
pyruvate 
9 YDR316W OMS1 IM-
IMS 
1 - with conserved 
methyltransferase motif; 
multicopy suppressor of 
respiratory defects caused by 
OXA1 mutations 
10 YFL036W RPO41 matrix - - RNA polymerase; enhancing 
DNA bending and melting to 
facilitate pre-initiation open 
complex formation 
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11 YFR011C AIM13 IMS - - subunit of mitochondrial IM 
organizing system (MitOS/ 
MICOS/ MINOS), role in 
maintenance of crista 
junctions and IM architecture 
12 YGL057C GEP7 IM 1 - unknown function; null 
mutant exhibits  respiratory 
growth defect and synthetic 
interactions with prohibitin 
(Phb1) and Gem1 
13 YGL068W MNP1 matrix - - protein associated with 
mitochondrial nucleoid, 
required for normal 
respiratory growth 
14 YGR029W ERV1 IMS - FAD flavin-linked sulfhydryl 
oxidase, oxidizes Mia40p as 
part of the disulfide relay 
system 
15 YGR076C MRPL25 matrix - - mitochondrial protein of the 
large ribosomal subunit 
16 YGR132C PHB1 IM-
IMS 
1 - inner mitochondrial 
membrane chaperone that 
stabilizes newly synthesized 
proteins 
17 YGR174C CBP4 IM-
IMS 
1 - required for assembly of 
cytochrome bc1 complex; 
interacts with the Cbp3-Cbp6 
complex and newly 
synthesized cytochrome b to 
promote assembly of 
cytochrome b into 
cytochrome bc1 complex 
18 YGR286C BIO2 matrix - iron, 
sulfur 
biotin synthase, catalyzes the 
conversion of dethiobiotin to 
biotin 
19 YHL021C AIM17 not 
known 
- iron unknown; null mutant 
displays reduced frequency 
of mitochondrial genome loss 
20 YHR005C TIM10 IMS - zinc essential IMS protein, forms 
a complex with Tim9 that 
delivers hydrophobic proteins 
to TIM22 complex for 
insertion into the IM 
21 YHR024C MAS2 matrix - zinc large subunit of 
mitochondrial processing 
protease (MPP), essential 
processing enzyme, cleaves 
the N-terminal targeting 
sequences from 
mitochondrially imported 
proteins 
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22 YIL155C GUT2 IM-
IMS 
1 FAD mitochondrial glycerol-3-
phosphate dehydrogenase 
23 YJL066C MPM1 not 
known 
- - unknown function, no 
hydrophobic stretches 
24 YJR045C SSC1 matrix - ATP Hsp70 family ATPase, 
constituent of the import 
motor component of TIM23 
complex, involved in protein 
translocation and folding 
25 YJR048W CYC1 IMS - heme, 
iron 
electron carrier of 
mitochondrial intermembrane 
space, transfers electrons 
from ubiquinone-cytochrome 
c oxidoreductase to 
cytochrome c oxidase during 
cellular respiration 
26 YJR100C AIM25 not 
known 
- - unknown function, null 
mutant viable/ displays 
elevated rate of 
mitochondrial genome loss 
27 YKL138C MRPL31 matrix - - mitochondrial ribosomal 
protein of the large subunit 
28 YKL150W MCR1 OM/I
MS 
1/- FAD, 
NAD 
mitochondrial NADH-
cytochrome b5 reductase, 
involved in ergosterol 
biosynthesis 
29 YKR016W FCJ1 IM-
IMS 
1 - ortholog of mammalian 
mitofilin, essential role in 
maintenance of crista 
junctions and IM 
architecture, component of 
mitochondrial IM organizing 
system (MICOS/ MitOS/ 
MINOS) 
30 YLL027W ISA1 matrix - - required for maturation of 
mitochondrial (4Fe-4S) 
proteins 
31 YLR168C UPS2 IMS - - role in regulation of 
phospholipid metabolism by 
inhibiting conversion of 
phosphatidylethanolamine to 
phosphatidylcholine 
32 YLR203C MSS51 matrix - - translational activator of 
mitochondrial COX1 mRNA; 
influences COX1 mRNA 
translation and Cox1 
assembly into cytochrome c 
oxidase 
33 YML025C YML6 matrix - - mitochondrial protein of the 
large ribosomal subunit 
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34 YMR115
W 
MGR3 IM-
IMS 
1 - subunit of mitochondrial i-
AAA protease which 
degrades misfolded 
mitochondrial proteins, binds 
to substrates to facilitate 
proteolysis, required for 
growth of rho0 cells 
35 YMR145C NDE1 IM-
IMS 
1  FAD, 
NAD 
mitochondrial external 
NADH dehydrogenase, 
catalyzes oxidation of 
cytosolic NADH providing it 
to the respiratory chain 
36 YMR203
W 
TOM40 OM-
IMS 
β-
barrel 
- component of the TOM 
complex, responsible for 
recognition and initial import 
steps for all mitochondrially 
directed proteins 
37 YNL100W AIM37 IM-
IMS 
2 - subunit of mitochondrial IM 
organizing system (MitOS/ 
MICOS/ MINOS), role in 
maintenance of crista 
junctions and IM architecture 
38 YNR018W RCF2 IM-
IMS 
2 - cytochrome c oxidase 
subunit; role in assembly of 
respiratory supercomplexes; 
required for late-stage 
assembly of the Cox12 and 
Cox13 and for cytochrome c 
oxidase activity 
39 YNR020C ATP23 IMS - zinc  metalloprotease of the IM, 
required for processing of 
Atp6; role in assembly of the 
F0 sector of the F1F0 ATP 
synthase complex 
40 YOR020C HSP10 matrix - - matrix co-chaperonin that 
inhibits the ATPase activity 
of Hsp60; involved in protein 
folding and sorting in 
mitochondria; similarity to E. 
coli groES 
41 YOR211C MGM1 IM-
IMS/ 
IMS 
1/- GTP GTPase; complex with Ugo1 
and Fzo1; required for 
mitochondrial morphology 
and genome maintenance; 
long and short form; homolog 
of human OPA1 involved in 
autosomal dominant optic 
atrophy 
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3.6.2 Endogenous levels of Yme1 substrates in Δyme1 strain 
The findings from the SILAC screen were confirmed by an independent method. For 
this purpose, the steady state levels of candidate proteins from the SILAC screen for 
which antibodies were available were determined in the Δyme1 and wild-type strains. The 
endogenous levels of Erv1, Mcs10, and Mcs27 were approximately two-fold higher in the 
absence of Yme1 (Fig. 22, left panel). This is remniscent of the behavior of DHFR in the 
absence of Yme1, and suggests that these proteins are also proteolytically turned over by 
Yme1. The steady-state levels of the other substrate candidates from the SILAC screen, 
Mcs19, Fcj1, Phb2, Gut2, and Dld1, were indistinguishable between wild-type and 
deletion strains (Fig. 22, left and middle panel), indicating that these proteins are not 
predominantly degraded by Yme1. The steady-state levels of a large number of other 
mitochondrial proteins residing in the four mitochondrial subcompartments, outer 
membrane, intermembrane space, inner membrane and matrix, were tested and none of 
them was affected in the absence of Yme1 (Fig. 22, middle and right panel). 
 
  
Figure 22. Steady state levels of endogenous proteins aggregated in Δyme1  
Endogenous levels of candidates from SILAC were analyzed in wild-type and Δyme1 
mitochondria. Isolated mitochondria (5 and 15µg) were analyzed by SDS-PAGE, western 
blot, and immuno-staining with antibodies against indicated proteins. WT, wild-type.  
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3.6.3 Aggregation of endogenous Yme1 substrates in mitochondria of Δyme1  
         strain 
In order to confirm the data form the SILAC screen, the aggregation assay was 
repeated and aggregate and soluble fractions were analyzed by SDS-PAGE, western blot 
and immuno-staining with antibodies against the substrate candidates from the SILAC 
screen. Importantly, Erv1, Phb2, Gut2, Mcs19 and Dld1 were indeed found in the 
aggregate fraction of Δyme1 but not of wild-type mitochondria (Fig. 23, left panel, lanes 
1+3). The aggregation propensity of these proteins was even increased by a short heat 
shock at 42 °C for 3 min. Interestingly, Mcs27 and Fcj1, two components of the recently 
identified mitochondrial contact site complex MICOS/MINOS/MitOS (Harner et al., 
2011, Hoppins et al., 2011, von der Malsburg et al., 2011) aggregated in the absence of 
Figure 23. Aggregation of endogenous substrates in Δyme1  
Mitochondria were pre-incubated for three minutes at 25 or 42 °C, solubilized with Triton X-
100-containing buffer and soluble, S and aggregate, P (pellet) fractions separated by 
centrifugation. Samples were analyzed by SDS-PAGE followed by immuno-staining with the 
indicated antibodies. The DHFR signals were quantified in supernatant and pellet fractions and 
expressed as percentages of total protein. ND, not detectable. 
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Yme1 only upon heat shock. This observation suggests that the chaperone-like function 
of Yme1 becomes more important under stress conditions. Notably, the in vitro folding of 
the sulfhydryl oxidase Erv1 was recently shown to depend on the introduction of disulfide 
bonds by Mia40 (Kallergi et al., 2012). My data, however, suggest that an additional 
player is involved in the folding of Erv1: Yme1. The elevated endogenous levels of Erv1 
and its aggregation in the absence of Yme1 indicate that Yme1 exerts a dual function. In 
the case of Erv1, Yme1 can switch between the proteolytic and the chaperone function. 
Aggregation of Erv1 in the absence of Yme1 could affect import of the substrates of the 
Mia-Erv1 disulfide relay system (Hell, 2008). Similarly, the aggregation of the 
intermembrane space dehydrogenases Dld1 and Gut2 could have secondary effects on the 
oxidative phosphorylation and thus respiratory growth (Grandier-Vazeille et al., 2011). 
And finally, aggregation of components of the MICOS/MINOS/MitOS complex (Mcs19, 
Mcs27, Fcj1) could affect the mitochondrial ultrastructure that is coordinated by this 
complex (Harner et al., 2011, Hoppins et al., 2011, von der Malsburg et al., 2011).  
Collectively, these data confirm that Yme1 has a role in folding of a multitude of 
structurally and functionally distinct proteins of the intermembrane space and the inner 
membrane. Aggregation of these substrate proteins in the absence of Yme1 would 
certainly affect their function and this in turn could lead to multiple secondary and 
tertiary effects. Considering the physiological functions of the identified Yme1 substrates, 
the aggregation of these proteins could explain the diverse aspects of the pleiotropic 
phenotype of Yme1. In addition, the data indicate that Yme1 has a broad substrate 
specificity that is not restricted to a particular subset of intermembrane space and inner 
membrane proteins. 
 
3.6.4 Characterization of Mpm1 
The candidate protein from the SILAC study that showed the highest aggregation in 
Δyme1 is Mpm1. Almost nothing is known about this protein, neither its 
submitochondrial localization nor its function. However, Mpm1 was co-isolated with 
Mcs10, a core component of the recently identified MICOS/MINOS/MitOS complex 
(Harner et al., 2011, Hoppins et al., 20122, von der Malsburg et al., 2011). This complex 
is located at contact sites between the inner and outer mitochondrial membranes and plays 
a crucial role in maintenance of the mitochondrial morphology. Interestingly, the 
mitochondrial morphology is also strongly affected in cells lacking Yme1 (Campbell et 
al., 1998; Stiburek et al., 2012). Therefore, I sought to analyze Mpm1 in more detail. For 
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this purpose, I generated a yeast strain containing a chromosomally myc-tagged version 
of Mpm1. Digitonin fractionation and alkaline extraction were performed to elucidate the 
localization of Mpm1. During digitonin fractionation, Mpm1 was accessible to externally 
added proteinase K (PK) as soon as the outer membrane was disrupted similar to the 
behavior of the inner membrane protein Tim50 (Fig. 24 A). When alkaline extraction was 
performed, Mpm1 was found in the soluble fraction (S), similar to the soluble matrix 
protein Hep1 (Fig. 24 B). Both results are consistent with the prediction programs, which 
suggest that Mpm1 has no transmembrane segments. Taken together, these results 
indicate that Mpm1 is a soluble protein of the mitochondrial intermembrane space. 
 
 
 
 
 
 
3.6.5 Effect of deletion of YME1 on Mpm1 expression levels 
Next, the behavior of Mpm1 in absence of Yme1 should be analyzed. Analysis of 
solubilized isolated mitochondria from cells harboring chromosomally myc-tagged 
Mpm1 by SDS-PAGE, western blot and immuno-staining showed that the steady state 
levels of Mpm1 are indistinguishable between the wild-type and YME1 deletion strains. 
This finding suggests that Mpm1 is not proteolytically turned over by Yme1 (Fig. 25).  
 
 
Figure 24. Submitochondrial localization of Mpm1 
Mitochondria harboring the myc-tagged version of Mpm1 were subjected to digitonin 
fractionation as described in Figure 11 (A) and carbonate extraction, CE (B). Samples were 
analyzed by SDS-PAGE, western blot and immuno-staining for the indicated proteins. P, 
pellet and S, soluble fraction after carbonate extraction. PK, proteinase K. 
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3.6.6 Aggregation of Mpm1 in the absence of Yme1 
Next, the aggregation assay was performed as described before with isolated 
mitochondria from cells harboring chromosomally myc-tagged Mpm1. The dependancy 
of the folding state of Mpm1 on the presence of Yme1 was clearly pronounced even 
under physiological conditions (Fig. 26, ’25 °C’). Heat treatment at 42 °C did not 
enhance the aggregation of Mpm1 in the deletion strain (Fig. 26, ’25 °C’). This result 
implies that the folding of Mpm1 is generally highly dependent on Yme1 and not only 
under stress conditions.  
Taken together, the localization of Mpm1, its endogenous levels and its aggregation 
behavior in the absence of Yme1 indicate that Mpm1 is a bona fide chaperone substrate 
of Yme1. 
Figure 25. Steady state levels of Mpm1 in Δyme1  
Isolated mitochondria (5, 15, and 30 µg) of cells expressing myc-tagged Mpm1 were 
solubilized, subjected to SDS-PAGE and western blot and analyzed by immuno-staining for 
indicated proteins. WT, wild-type. 
 
Figure 26. Aggregation of Mpm1 in Δyme1  
Mitochondria of cells expressing myc-tagged Mpm1 were pre-incubated for three minutes 
at 25 or 42 °C, solubilized with Triton X-100-containing buffer and soluble, S and 
aggregate, P (pellet) fractions were separated by centrifugation. Samples were analyzed by 
SDS-PAGE, western blot and immuno-staining with the indicated antibodies. WT, wild-
type. 
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3.6.7 Co-isolation of endogenous substrates of Yme1 with His-tagged Yme1 
Finally, I wanted to determine if Yme1 interacts directly with the newly identified 
endogenous substrates. To answer this question, isolated mitochondria from a strain 
harboring N-terminally His-tagged Yme1 were pre-treated with ADP or ATP and 
solubilized with digitonin-containing buffer. His-tagged Yme1 was captured with Ni-
NTA agarose beads and isolated. Samples of the mitochondrial lysate (total), the 
supernatant after capturing (flow through) and the eluates were subjected to SDS-PAGE, 
western blot and immuno-staining. The membrane was stained with antibodies against the 
newly identified Yme1 substrates.  
 
 
Figure 27. Co-isolation of Gut2 with His-tagged Yme1 
Isolated mitochondria of cells expressing N-terminally His-tagged Yme1 were solubilized 
with digitonin-containing buffer in the presence of ATP or ADP. Samples were incubated 
with Ni-NTA agarose beads and specifically bound proteins eluted with Laemmli buffer 
containing 500 mM imidazol. Total (T, 10 %), flow through (FT, 10 %), and eluate (E, 100 
%) fractions were analyzed by SDS-PAGE and immuno-staining with the indicated 
antibodies. WT, wild-type. 
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Gut2 was specifically co-isolated with His-tagged Yme1 in the presence of ADP but 
not in the presence of ATP (Fig. 27, lanes 6+12). As described before, this behavior is 
characteristic for most substrate-chaperone interactions. In the presence of ADP, the 
substrate binds to the chaperone but does not get processed. Therefore, the interaction 
between substrate and chaperone is longer than in the presence of ATP and is thus easier 
to detect by western blot and immuno-staining. None of the other tested newly identified 
Yme1 substrates was co-isolated with Yme1 under these conditions. 
As discussed before, the endogenous levels of Gut2 were unaffected in absence of 
Yme1 but Gut2 aggregated in the YME1 deletion strain. These findings and the 
confirmation of a direct interaction of Gut2 and Yme1 provide evidence that Gut2 is a 
substrate of the chaperone-like activity of Yme1. 
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4. DISCUSSION 	  
4.1 Folding of the model substrate DHFR in the mitochondrial   
      intermembrane space 
 
Mitochondria originate from bacterial ancestors that were engulfed by a progenitor 
of eukaryotic cells (Gray, 1999). They are thus surrounded by two bilayers of protein-
lipid membranes. In the course of time, a transfer of prokaryotic DNA to the eukaryotic 
nucleus took place. Therefore, nowadays, 99 % of mitochondrial proteins are encoded in 
the nucleus (Reichert and Neupert, 2004). A sophisticated translocation system evolved in 
order to transport these cytosolically synthesized proteins back to the organelle. 
Furthermore, the mitochondrial inner membrane and the matrix are entirely shielded from 
the cytosol and are not accessible to the cytosolic protein quality control systems. Thus, 
intrinsic protein quality control systems have developed to maintain mitochondrial 
protein homeostasis. 
The majority of the components of the matrix-located protein quality control system 
are derived from the bacterial ancestor and exert similar functions as their homologs in 
today’s bacteria and the eukaryotic cytosol (Sauer and Baker, 2011). These components 
have been studied in detail and structural and functional data are available. In contrast, 
very little is known about potential components or functions of a protein quality control 
system in the mitochondrial intermembrane space. Nevertheless, it is certain that such a 
system must exist. The mitochondrial IMS harbors many large and complex proteins and 
it is very unlikely that they assume their native fold without the assistance of molecular 
folding helpers (Herrmann and Neupert, 2003). The AAA protease Yme1 belongs to the 
proteolytic branch of the protein the quality control in the intermembrane space. It is 
involved in the turnover of soluble and membrane-anchored intermembrane space 
proteins.  
One subset of relatively small proteins is imported and also folded by the recently 
discovered the Mia40-Erv1 disulfide relay system (Deponte and Hell, 2009; Koehler and 
Tienson, 2009; Herrmann and Riemer, 2012). Substrates of this pathway harbor 
conserved cysteine residues in the form of CX3C or CX9C motifs. Upon translocation 
through the TOM pore, the substrates interact with oxidized Mia40. It is assumed that the 
introduction of one or more disulfide bonds by Mia40 is sufficient to trigger folding of 
the entire substrate protein (Milenkovic et al., 2007; Banci et al., 2010). 
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In order to elucidate the folding processes in the mitochondrial intermembrane space, 
I targeted the frequently used model substrate mouse DHFR to the intermembrane space 
of yeast mitochondria. I fused DHFR behind the bipartite presequence of the endogenous 
intermembrane space protein cytochrome b2 (IMS-DHFRWT). The hybrid protein was 
then expressed in vivo in a wild-type yeast strain. The folding state of the model substrate 
was analyzed under physiological (25 °C) and stress (42 °C) conditions. Upon heat stress, 
the model substrate aggregated in the intermembrane space in a nucleotide dependent 
manner. In presence of ATP, the aggregation was significantly lower than without 
nucleotides. This observation hints at the presence of an ATP-dependent folding helper 
that prevents the model substrate from aggregation. 
 
4.2 Role of Yme1 in folding of the model substrate DHFR 
Next, a screen for potential folding helpers was performed. His-tagged IMS-
DHFRWT was pulled down and co-isolated proteins were identified by mass spectrometry. 
Yme1, the i-AAA protease of the mitochondrial inner membrane (Koppen and Langer, 
2007), was found to specifically co-purify with the model substrate. Six Yme1 subunits 
form a homo-hexameric ring structure that is integrated into the inner membrane. The 
catalytic sites of Yme1 are exposed to the intermembrane space. Yme1 shows 
overlapping substrate specificity with its matrix-facing counterpart, m-AAA protease. 
Both proteins mediate the cooperative turnover of inner membrane proteins (Leonhard et 
al., 2000). Cox2 and Nde1 were the only confirmed proteolytic substrates of Yme1 for a 
long time (Nakai et al., 1995; Pearce and Sherman, 1995; Weber et al., 1996; Kominsky 
et al., 2002; Augustin et al., 2005; Graef et al., 2007; Dunn et al., 2008; Potting et al., 
2010; Elliott et al., 2011). Only recently, diverse screening approaches in yeast revealed 
further proteolytic substrates. The rapid proteolytic turnover of Ups1 and Ups2, two 
proteins involved in the phospholipid metabolism of the inner mitochondrial membrane, 
is mediated by Yme1 (Osman et al., 2009a; Tamura et al., 2009; Potting et al., 2010; 
Tamura et al., 2012). Furthermore, it was recently shown that the prohibitins, Phb1 and 
Phb2, protein and lipid scaffolds, are proteolytic substrates of Yme1 (Graef et al., 2007; 
Osman et al., 2009b). Already thirteen years ago, Leonhard et al. suggested a chaperone-
like activity of Yme1 based on in vitro experiments (Leonhard et al., 1999). The isolated 
AAA domain of Yme1 was able to restore the activity of two model substrates, DHFR 
and rhodanese upon denaturation with urea. However, these in vitro studies have not been 
confirmed in vivo so far (Leonhard et al., 1999).  
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In the present in vivo study, it was observed that IMS-DHFRWT aggregates in the 
absence of Yme1 even under physiological conditions. This finding strongly underlines 
the fact that Yme1 indeed has a chaperone-like function and that the model substrate in 
the intermembrane space depends on this function. Importantly, the two isoforms of IMS-
DHFRWT, behaved differently in the absence of Yme1. The mature form that is fully 
processed was distributed equally between soluble and aggregate fractions. However, the 
intermediate form that is not processed by the inner membrane protease was found 
predominantly in the aggregate fraction. This observation shows that the membrane-
bound intermediate form, that is cleaved only once, depends to a greater extent on the 
presence of Yme1. The folding of membrane bound proteins may pose an even greater 
challenge to protein quality control systems than the folding of soluble proteins. In 
addition, Yme1 mediates proteolytic turnover of IMS-DHFRWT substantiated by 
increased levels of the model substrate in the Δyme1 strain. Importantly, a recent in vivo 
study reported similar findings on a chaperone-like function of Yme1 (Fiumera et al., 
2009). Fiumera et al. showed that Yme1 promotes the folding of Cox2 and probably 
assembly of Cox2 into the cytochrome c oxidase complex of the inner membrane. 
In conclusion, Yme1 seems to monitor both processes: the folding and the 
proteolytic turnover of the model substrate IMS-DHFRWT. It is conceivable that Yme1 
mediates de novo folding of IMS-DHFRWT upon import. Upon several unsuccessful 
folding attempts, Yme1 could then switch to the proteolytic mode and degrade the 
unfolded or misfolded DHFR construct. However, the question how Yme1 can “decide” 
between the proteolytic mode and the chaperone-like mode remains unanswered. 
Interestingly, a similar working mechanism has recently been hypothesized for AAA 
proteases in general (Sauer and Baker, 2011). Future studies are needed to answer this 
question conclusively. 
 
4.3 Endogenous substrates of the chaperone-like activity of Yme1 
In order to identify endogenous substrates of the chaperone-like activity of Yme1, I 
analyzed the endogenous proteins that aggregate in the absence of Yme1. Wild-type 
strain and Δyme1 strain were labeled with heavy and light isotopes of lysine in cell 
culture (SILAC). The aggregate fractions of wild-type and Δyme1 strain were thus 
distinguishable from one another and could be analyzed simultaneously by mass 
spectrometry. I identified a number of very diverse endogenous proteins that aggregated 
in the absence of Yme1. One of the aggregating proteins, Ups2, is a confirmed proteolytic 
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susbtrate of Yme1. This indicates that Ups2 is not only turned over by Yme1 (Potting et 
al., 2010), but also dependent on Yme1 to assume and maintain its mature tertiary 
structure. The deletion of YME1 probably results in an impaired biogenesis of functional 
Ups2. The physiological function of Ups2 is in regulation of the phospholipid metabolism 
of the inner membrane (Osman et al., 2009b), and this could be the underlying 
mechanism causing an altered phospholipid composition of mitochondria in the Δyme1 
strain (Nebauer et al., 2007). Furthermore, three components that are involved in cellular 
respiration, have been found to aggregate in the absence of Yme1: Dld1, Gut2 and Cox2, 
the confirmed proteolytic substrate of Yme1. Dld1 and Gut2 are dehydrogenases of the 
intermembrane space and Cox2 is a subunit of the cytochrome c oxidase complex in the 
inner membrane (Taanman and Capaldi, 1992; Khanday et al., 2002; Steinmetz et al., 
2002; Lu et al., 2003). This could represent the underlying mechanism for the respiratory 
deficiency of YME1 deletion strain and the associated growth phenotype on non-
fermentable carbon sources (Thorsness et al., 1993). As discussed before, Fiumera et al. 
also suggest that Yme1 is not only involved in the degradation of Cox2 (Fiumera et al., 
2009). Their findings suggest that Yme1 chaperones the folding and/or assembly of 
Cox2. In contrast to the degradation of Cox2 by Yme1, this process seems to be 
independent of the two potential adaptor proteins Mgr1 and Mgr3. 
Interestingly, Mpm1 has the highest aggregation propensity of all proteins identified 
in the Δyme1 strain in the SILAC approach. Yet, almost nothing is known about this 
mitochondrial protein. Inadome et al. studied the submitochondrial localization of Mpm1 
but the results are contradictory (Inadome et al., 2001). In their study, Mpm1 was found 
in the membrane fraction after alkaline extraction. However, the primary sequence does 
not contain any segments that could function as transmembrane domains. In a recent 
screen for proteins of the mitochondrial contact site complex, Mpm1 was detected 
amongst the soluble protein fraction (Harner M., personal communication). In the present 
study, I could confirm that Mpm1 is a soluble protein of the mitochondrial 
intermembrane space. This localization makes Mpm1 a suitable substrate for Yme1.  
Importantly, in a recent study on the mitochondrial contact site complex, Mpm1 was 
co-isolated with Mcs10 (Hoppins et al., 2011), a component of this complex, named 
MICOS/MINOS/MitOS (Harner et al., 2011; Hoppins et al., 2011; von der Malsburg et 
al., 2011). MICOS links the inner boundary membrane and the outer mitochondrial 
membrane at cristae junctions (Harner et al., 2011). In the present study, I identified the 
MICOS component Fcj1 in the SILAC screen for endogenous Yme1 substrates. Indeed, 
Fcj1 and two further components of MICOS, Mcs19 and Mcs27, were confirmed by 
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western blot and immuno-staining to aggregate in the absence of Yme1. The deletion of 
two components of the MICOS complex, Fcj1 and Mcs10, leads to a strongly reduced 
amount of cristae junctions and mitochondrial branches (Harner et al., 2011). This results 
in largely altered mitochondrial architecture as confirmed by electron microscopy. 
Similarly, the deletion of Yme1 also induces a severe defect in mitochondrial 
ultrastructure with grossly swollen and punctate mitochondria (Campbell et al., 1994; 
Campbell and Thorsness, 1998). This phenotype is distinguishable from the structural 
changes observed in Δfcj1 or Δmcs10 strains. Nevertheless, both phenotypes could result 
from similar underlying mechanisms originating from changes in the composition of 
MICOS/MINOS/MitOS complex.  
The prohibitins Phb1 and Phb2 also aggregate in the absence of Yme1. This confirms 
that prohibitins are not only proteolytic substrates of Yme1 (Osman et al., 2009b). They 
also rely on the chaperone-like activity of the Yme1 to assume and/or maintain their 
mature fold. Prohibitins were shown to represent protein and lipid scaffolds. Their 
aggregation in the absence of Yme1 might cause a multitude of different phenotypes. Any 
aspect of the Δyme1 phenotype could be explained by the aggregation of the prohibitins. 
The aggregation of prohibitins could likely induce secondary effects on proteins that rely 
on Phb1 and Phb2 for their function or localization. Furthermore, prohibitins were shown 
to form a supercomplex with m-AAA protease in the inner membrane (Steglich et al., 
1999). Deletion studies revealed a regulatory function of prohibitins on the degradation of 
membrane proteins by m-AAA protease (Steglich et al., 1999). Thus, aggregation of 
prohibitins in the absence of Yme1 might have profound effects on the activity of the m-
AAA protease. The aggregation of the prohibitins could affect the activity of the m-AAA 
protease and this, in turn, would affect substrates of the m-AAA protease. 
Interestingly, a significant amount of Erv1 aggregated in the absence of Yme1. Erv1 
is the sulfhydryl oxidase of the disulfide relay system and itself a substrate of Mia40 
(Hell, 2008; Kallergi et al., 2012). Until now, it was assumed that the introduction of 
disulfide bonds into the substrates of the Mia40-Erv1 disulfide relay system is a necessary 
and sufficient step to trigger folding of the entire, typically small substrate proteins. Erv1 
is, however, significantly larger than most substrates of the disulfide relay system. The 
disulfide bond that is introduced by Mia40 is located in a very distal part of the 
polypeptide chain. It is conceivable that in the case of Erv1, the introduction of the 
disulfide bond is not sufficient for folding of the entire protein. Yme1 may thus be 
required to fold the residual part of the polypeptide chain of chain of Erv1. 
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 In conclusion, the Yme1 substrates identified in the SILAC screen are certainly not 
uniform in terms of their import pathways, localization, size, structure and function. This 
points to a broad influence of Yme1 on diverse subsets of intermembrane space proteins. 
With this in mind, one can imagine a highly interrelated and interconnected network of 
folding and translocation systems, which were previously considered unrelated. 
Regarding the diversity of mitochondrial precursor proteins, an translocation and folding 
system that is fine-tuned and adapted to the needs of each individual substrate is not 
unlikely. Besides, it is almost normal that proposed molecular mechanisms are revealed 
to be more complex than previously expected. It will still be a long time, with intensive 
research in this field, before all interconnections between the diverse translocation and 
folding pathways are revealed and understood. 
I observed that the endogenous levels of most of the newly identified Yme1 
substrates are unaffected in the absence of Yme1, suggesting that Yme1 is not involved in 
the degradation of these substrates. This indicates that Yme1 is able to uncouple the 
proteolytic activity and the chaperone-like activity under certain circumstances. 
Chaperones and proteases closely interact in the maintenance of protein homeostasis, and 
there are several examples in the protein quality control systems where both functions are 
present on the same polypeptide chain. FtsH and LON protease both have this double 
function, whereas ClpP protease has to assemble with ClpX, a separate partner chaperone, 
to form the functional AAA protease (Moliere and Turgay, 2009). However, both 
components, ClpX and ClpP alone can also act independently under certain 
circumstances. It remains to be elucidated if all AAA proteases can switch from the 
degradation to the chaperoning mode and which factors determine this transition (Sauer 
and Baker, 2011). It is possible that Yme1 acts as chaperone in a first step, assisting the 
folding of proteins. After unsuccessful folding attempts, Yme1 could switch to the 
proteolytic mode and degrade the non-folded substrates in order to prevent deleterious 
effects on the rest of the cell. It is even conceivable that Yme1 acts as remodeler or 
disaggregase, converting aggregated or misfolded proteins back to a folding-competent 
state. It is interesting that for the m-AAA protease, such an isolated ATPase activity has 
already been reported. The m-AAA protease mediates membrane dislocation of the 
precursor of Ccp1 as a prerequisite for cleavage of Ccp1 by the rhomboid protease Pcp1 
(Esser et al., 2002). In this process, the proteolytic activity of m-AAA protease is 
dispensable (Tatsuta and Langer, 2007).  
Gut2, one of the newly identified endogenous substrates of Yme1, was specifically 
co-isolated with Yme1 in the presence of ADP. In the presence of ATP, however, no co-
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isolation was detected. This reminds one of typical substrate-chaperone interactions. In 
the presence of the ATP, the interaction is too short-lived to be detected. In the presence 
of ADP, the substrate binds to the chaperone but does not get processed. Therefore, the 
interaction lasts longer and is thus easier to trace. 
Besides Yme1, Mgr1 and Mgr3 were specifically co-isolated with IMS-DHFRWT by 
Ni-NTA pulldown. Mgr1 and Mgr3 are anchored in the mitochondrial inner membrane 
and form a supermolecular complex with Yme1. Both proteins have been suggested to 
function as adaptors for the proteolytic substrates of Yme1 (Dunn et al., 2008). For future 
experiments, it will be important to analyze MGR1, MGR3 or double deletion strains in 
detail. The steady state levels and the folding state of the model substrate IMS-DHFRWT 
and of the newly identified endogenous Yme1 substrates in this background should be 
determined. This could answer the question of whether the adaptor proteins are needed 
only for efficient processing of proteolytic substrates or also for the substrates of the 
chaperone-like activity. 
 
4.4 Folding in the mitochondrial intermembrane space - unconventional    
      pathways 	  
Members of the classical chaperone families have not been detected in the 
mitochondrial intermembrane space so far. However, the presence of atypical chaperones 
cannot be excluded. The situation is further complicated by the fact that some known 
chaperones, such as trigger factor in bacteria or the group of small heat shock proteins, 
operate in an ATP-independent mode (Ferbitz et al., 2004; Haslbeck et al., 2005). This 
makes their identification even more difficult.  
Additionally, a dual localization of a number of origininally “only cytosolic” or 
“only mitochondrial” proteins seems to be more abundant than expected. In that sense, 
one quarter of the mitochondrial proteome has a dual localization (Dinur-Mills et al., 
2008; Yogev and Pines, 2011). Interestingly, the dual localized proteins, designated 
echoforms, often exert completely different functions in the different compartments (Ben-
Menachem et al., 2011; Yogev et al., 2011). This underlines the possibility of the 
presence of classical cytosolic chaperones in the intermembrane space of mitochondria 
that have simply not been detected yet. And moreover, non-chaperone proteins of the 
cytosol or other cellular compartments may have “echoforms” in mitochondria that 
function as chaperones in this compartment.  
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A recent study in fungi on peroxisomal proteostasis suggested that Pln, a 
representative of the LON protease family, exerts a chaperone-like function 
(Bartoszewska et al., 2012). Pln, Yme1 and other AAA proteases could possibly function 
in several different modes, ranging from chaperone to chaperone-protease-coupled, or 
protease activity. This finding underlines the possibility that other “well-known” proteins 
may also have in fact many more functional modes than expected and investigated until 
today.  
Furthermore, some components of the mitochondrial translocation systems have 
recently been proposed to be involved in the folding of their substrates. It was shown that 
TOM complex can accommodate and transport a precursor protein containing two 
helices. This raises the possibility that folding could already start inside the TOM 
complex (Ahting et al., 1999). Moreover, it has been shown that TOM binds unfolded 
polypeptides and by this prevents their aggregation (Esaki et al., 2003). Due to the limited 
space inside the translocation channel, proteins will probably not fold completely with the 
help of the TOM complex. However, it could provide the initiating folding step and 
further folding of the protein would be taken over by downstream chaperones.  
Notably, the small TIM proteins have been suggested to exert a chaperone-like 
activity in the mitochondrial intermembrane space. Small TIM complexes shield the 
hydrophobic residues of incoming preproteins and escort these proteins through the 
intermembrane space to the TOB translocase in the outer membrane, or to the TIM22 
translocase in the inner membrane (Neupert and Herrmann, 2007; Chacinska et al., 2009; 
Endo and Yamano, 2009). It is conceivable that folding of some substrate proteins 
already occurs during transport through the intermembrane space. And indeed, recent 
evidence confirms that the precursor of Tim23 can partly fold upon interaction with 
Tim8-Tim13 and Tim9-Tim10 complex (Davis et al., 2007). Similarly, the 
intermembrane space domains of Tim50 and Tim23 could serve as folding platforms for 
substrates of the TIM23 complex. In this context, it was recently shown that the 
intermembrane space domain of Tim23 is intrinsically disordered (Gevorkyan-Airapetov 
et al., 2009; de la Cruz et al., 2010). Recently, such domains were suggested to exert 
chaperone-like functions (Dyson and Wright, 2005).  
Similar to the TOM complex, Yme1 could provide a folding platform triggering the 
initial folding steps of translocating preproteins already during import. Subsequently, it 
could pass them on to downstream chaperones. The initial folding steps could even have a 
function in promotion of the ongoing import and prevention from retrograde transport of 
parts of the polypeptide. In this context, it is interesting to see that Yme1 seems to be 
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involved in the import of human polynucleotide phosphorylase (PNPase) into yeast 
mitochondria (Rainey et al., 2006). However, PNPase is an ectopically expressed protein 
and it remains to be elucidated if Yme1 is also involved in the import of endogenous 
proteins and whether this applies for all or only a special subset of imported polypeptides.  
In conclusion, it seems evident that the folding systems of the intermembrane space 
are rather “unconventional”. They seem to differ significantly from all other known 
chaperone systems present in the cytosol of bacteria and eukaryotes or in the 
mitochondrial matrix. Moreover, it is obvious that several diverse folding pathways exist. 
These pathways are interconnected and cooperate with each other according to the 
substrate to be handled.  
4.5 The human i-AAA protease 
A recent study addressed the characterization of YME1L, the human ortholog of 
Yme1 (Coppola et al., 2000; Shah et al., 2000; Stiburek et al., 2012). Stiburek et al. 
showed that YME1L resembles its yeast counterpart in many aspects. Similar to Yme1, 
YME1L is anchored to the mitochondrial inner membrane and forms complexes of high 
molecular weight. Furthermore, stable knockdown of YME1L in mammalian cells by an 
elegant RNA interference approach revealed a pleiotropic phenotype that overlaps in 
many aspects with the phenotype of the deletion of YME1 in yeast. The YME1L knockout 
cells showed a respiratory deficiency that was attributed to an impaired activity of 
complex I of the respiratory chain. YME1L is one of the proteases that mediate the 
processing of the dynamin-like GTPase OPA1. The ratio of long to short isoforms of 
OPA1 determines mitochondrial dynamics (fusion and fission) and cristae morphology 
(Griparic et al., 2007; Song et al., 2007). The strong morphological phenotype of YME1L 
knockdown cells with its markedly altered mitochondrial network and a largely 
disorganized cristae morphology is probably attributed to an altered ratio of long to short 
OPA1 isoforms. Furthermore, YME1L knockout cells showed a significant decrease in 
cell proliferation that is, at least in part, a result of an increased rate of apoptosis. The 
increased susceptibility of YME1L knockout cells to programmed cell death seems to 
result from an impaired prevention of the accumulation of oxidatively damaged 
mitochondrial membrane proteins. 
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4.6 Protein quality control in the light of neurodegenerative diseases 
For future research, it will be of great interest to characterize the folding system of 
the mitochondrial intermembrane space in the context of neurodegenerative diseases and 
ageing. During the last years, scientists revealed extensive connections between defects in 
the protein quality control systems and such neurological disorders as hereditary spastic 
paraplegia (HSP) and spinocerebellar ataxia (SCA) (Koppen and Langer, 2007; Tatsuta 
and Langer, 2008). In both cases, mutations of the human m-AAA protease, the matrix-
facing counterpart of YME1L, are the cause for pathogenesis. Similarly, the prominent 
neurological disorders Parkinson’s disease, Alzheimer’s disease and Huntington’s 
disease, which share the occurrance of amyloidogenic aggregates, are based on the failure 
of protein quality systems (Muchowski, 2002; Ross and Poirier, 2004; Muchowski and 
Wacker, 2005; Ross and Poirier, 2005; Morimoto, 2008). Again, pathogenesis is induced 
by the dysfunction of components of the protein quality control system. In Alzheimer’s 
disease, the matrix protease PreP (Falkevall et al., 2006; Rugarli and Langer, 2012) or 
components of the γ-secretase (Hedskog et al., 2011; Pavlov et al., 2011) are mutated. In 
Parkinson’s disease, mutations have been indentified in a multitude of components of the 
protein quality control systems: Htr2A/OMI (Strauss et al., 2005; Kawamoto et al., 2008) 
PARL (Rugarli and Langer, 2012), Parkin (Kitada et al., 1998) or PINK1 (Valente et al., 
2004). 
The tissue-specific manifestation of these diseases is striking. It can be explained by 
some common characteristics of neurons, the cells that are usually most affected. Neurons 
have a very special shape with extremely long axons and a multitude of dendrites. Thus, 
they rely -more than other cells- on functional mitochondria that provide the enormous 
amounts of energy needed for neuronal signaling. As neurons are post-mitotic and 
terminally differentiated, they are strictly dependent on intact mitochondria. Mitochondria 
are the main suppliers of energy in the form of ATP. Therefore, they are strongly exposed 
to reactive oxygen species that are the by-products of oxidative phosphorylation (Murphy 
et al., 2011). Reactive oxygen species cause damage of DNA and proteins.  
Mitochondrial DNA repair mechanisms and protein quality control systems can restore 
the integrity of these macromolecules. The capacity of the mitochondrial quality control 
system can even be expanded by the upregulation of mitochondrial chaperones and 
proteases. The increased transcription and translation of components of the mitochondrial 
quality control system is induced by the accumulation of misfolded or unfolded proteins. 
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This control circuit is therefore referred to as mitochondrial unfolded protein response 
(Zhao et al., 2002; Tatsuta, 2009; Haynes and Ron, 2010).  
With increasing age, the capacity of the protein quality control systems seems to 
decrease dramatically and thus, misfolded protein species accumulate in a stepwise 
manner. This explains the late onset of many of these neurodegenerative diseases (Ross 
and Poirier, 2005; Hartl et al., 2011). Protein aggregates are the characteristic feature of 
most neurodegenerative diseases. However, it is not yet clear if these aggregates are 
cytotoxic. Recent studies suggest that aggregates are indeed toxic because they sequester 
and block components of the protein quality control systems. Thus, the sequestered 
components of the protein quality control systems are unavailable in cases of cellular 
stress emergency (Brignull et al., 2007; Chen et al., 2011; Olzscha et al., 2011). 
With regard to diagnosis and treatment of the growing list of neurodegenerative 
diseases, it will be of particular interest to unravel the underlying mechanisms on the 
molecular level in detail. It is conceivable that mutations of YME1L in humans play a 
crucial role in the development of diverse neurodegenerative diseases, similar to the role 
of m-AAA protease in hereditary spastic paraplegia and spinocerebellar ataxia. To this 
end, further endogenous substrates of Yme1/YME1L have to be identified and analyzed. 
It will be a great challenge to find common principles on the molecular level and such 
principles could constitute the starting point for the development of adequate treatments. 
It is also possible, however, that each patient develops the disease on the basis of a 
largely unique and individual set of causes. In this case, it will be necessary to record the 
entire pattern of changes on the molecular level in order to develop an individually 
tailored treatment. This approach is already used in cancer treatment and is known as 
“personalized medicine” (Bianchi, 2012; de Cuba et al., 2012).  
In the future, it will be particularly important to promote interdisciplinary studies, 
combining basic research, genetics and clinical research. Only an interdisciplinary 
approach can reveal the correlations between molecular events and clinical symptoms and 
finally find causal therapy. 
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5. SUMMARY 
 
The vast majority of mitochondrial proteins are encoded in the nucleus and synthesized as 
precursor proteins on cytosolic ribosomes. After translation, these precursor proteins are 
imported in a largely, if not completely, unfolded state into one of the four mitochondrial 
subcompartments, the outer membrane, the intermembrane space, the inner membrane or 
the matrix.  
Once the precursor proteins reach their compartment of destination, they can fold 
into the functionally active three-dimensional native structure. Therefore, internal 
mitochondrial folding systems are needed in each subcompartment to assist folding of 
these precursor proteins upon import. Members of several “classical” chaperone families 
are present in the mitochondrial matrix and have been shown to support import and 
folding of newly imported polypeptides. However, folding of proteins in the 
mitochondrial intermembrane space is only poorly understood. Recently, a disulfide relay 
system in the intermembrane space that mediates import and folding was described, but 
this system is limited to proteins that form disulfide bonds. For the majority of 
intermembrane proteins, folding helpers that promote folding have not yet been 
discovered. 
In order to identify general folding helpers of the intermembrane space, the well 
studied model substrate mouse dihydrofolate reductase (DHFR) was targeted to the 
mitochondrial intermembrane space of S. cerevisiae and its folding analyzed. DHFR 
assumes its mature fold in the intermembrane space and heat shock induces DHFR 
aggregation. Interestingly, aggregation is counteracted by an ATP-dependent process. 
The i-AAA protease Yme1 that is anchored in the inner mitochondrial membrane and 
exposes its functional domains to the intermembrane space was able to prevent the 
aggregation of DHFR.  
A number of proteins of diverse structural and functional classes were found in the 
aggregate fractions of mitochondria lacking Yme1. Amongst them were factors that are 
involved in the establishment and maintenance of the mitochondrial ultrastructure, lipid 
metabolism, protein translocation and respiratory growth. 
 Considering the diversity of the proteins affected in the absence of Yme1 and their 
function in mitochondria, the pleiotropic effects of the deletion of Yme1 can be readily 
explained. The findings of the present in vivo study confirm previous hints to a 
chaperone-like function of Yme1 resulting from in vitro experiments. Yme1 thus has a 
	   	   SUMMARY	  
 
	   104	  
dual role as protease and as chaperone and occupies a key position in the protein quality 
control system of the mitochondrial intermembrane space. 	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7. ABBREVIATIONS 
 
A Ampère 
AAA triple A domain 
AAC ADP/ ATP carrier 
ADP adenosine diphosphate 
Amp ampicillin 
APS ammonium peroxodisulfate 
ATP adenosine triphosphate 
ATPase adenosine triphosphatase 
BSA bovine serum albumin 
C- carboxy- 
CAT carboxy atractyloside 
CBB coomassie brilliant blue 
CCCP carbonyl cyanide m-chlorophenylhydrazone 
cDNA complementary DNA 
c- centi- 
Cyb2 Cytochrome b2 
DHFR dihydrofolate reductase 
DMSO dimethylsulfoxid 
DNA desoxyribonucleic acid 
DTT dithiotreitol 
Δ delta 
dNTP deoxyribonucleoside triphosphate 
ECL enhanced chemiluminescence 
E. coli Escherichia coli 
EDTA ethylendiamine tetraacetate 
g gram 
g gravity 
gDNA genomic DNA 
Hepes N-2 hydroxyl piperazine-N’-2-ethane sulphonic acid 
His6 hexahistidine polypeptide 
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Hsp heat shock protein 
H. sapiens Homo sapiens 
IgG immunoglobulin G 
IM inner membrane 
IMP inner membrane peptidase 
IMS intermembrane space 
IPTG isopropyl-β,D-thiogalactopyranoside 
kDa kilo Dalton 
kg kilogram 
l liter 
LB Luria Bertani 
LysC endoprotease hydrolyzing at Lys-C-terminus 
m meter 
m- milli- 
MBP maltose-binding protein 
min minute 
MPP mitochondrial processing peptidase 
MS mass spectrometry 
MTS matrix targeting signal 
MTX methotrexate 
M. musculus Mus musculus 
myc- polypeptide derived from c-myc gene product 
µ- micro- 
N- amino- 
NADH nicotine amide adenine dinucleotide 
NADPH nicotine amide adenine dinucleotide phosphate 
Ni-NTA nickel-nitrilo triacetic acid 
ODx optical density at x nm 
OM outer membrane 
OXA oxidase assembly protein 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PEG polyethylene glycol 
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PI preimmune serum 
PIR protease inhibitor reagent (Roche) 
PK proteinase K 
PMSF phenylmethylsulfonylfluoride 
RNA ribonucleic acid 
RNasin ribonuclease inhibitor 
rpm rounds per minute 
RT room temperature 
S. cerevisiae Saccharomyces cerevisiae 
SDS sodium dodecyl sulfate 
SILAC stable isotope labeling of amino acids in cell culture 
TBS TRIS-buffered saline 
TCA trichloroacetic acid 
TEMED N.N.N’,N’-tetramethylene diamine 
TIM translocase of the inner mitochondrial membrane 
TOM translocase of the outer mitochondrial membrane 
TRIS tris-(hydroxymethyl)-aminomethane 
Tx-100 TritonX-100 
U Unit(s) 
V Volt 
v/v volume per volume 
w/V weight per volume 
WT wild-type 
Xh hydrophobic 
Δψ membrane potential 
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